Genes	Process	name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
23194;	GO:0000086	G2/M transition of mitotic cell cycle	1	130	0.769230769230769	0.471931602025051	0.486109804660997	1	1	0.907423808073593	0.907423808073593	1
2099; 2737; 2260; 2625; 5396; 7291; 165; 29995;	GO:0000122	negative regulation of transcription by RNA polymerase II	8	774	1.03359173126615	0.0361549065072999	0.0826325117262046	1	1	0.907423808073592	0.907423808073593	0.615171755644577
2260;	GO:0000165	MAPK cascade	1	269	0.371747211895911	0.733009239500559	0.737619360503707	1	1	0.907423808073593	0.907423808073593	1
7043;	GO:0000187	activation of MAPK activity	1	117	0.854700854700855	0.437284666796186	0.452363448409848	1	1	0.907423808073593	0.907423808073593	1
23194;	GO:0000209	protein polyubiquitination	1	239	0.418410041841004	0.690547390424805	0.696350309672072	1	1	0.907423808073593	0.907423808073593	1
83987;	GO:0000226	microtubule cytoskeleton organization	1	101	0.99009900990099	0.39153981848192	0.408119680502327	1	1	0.907423808073593	0.907423808073593	1
23194;	GO:0000278	mitotic cell cycle	1	122	0.819672131147541	0.450868964502996	0.465413124648254	1	1	0.907423808073593	0.907423808073593	1
348; 347;	GO:0000302	response to reactive oxygen species	2	12	16.6666666666667	0.00203778608079697	0.0216852801389006	1	1	0.425897290886566	0.907423808073593	0.161439747818551
60681;	GO:0000412	histone peptidyl-prolyl isomerization	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
60681;	GO:0000413	protein peptidyl-prolyl isomerization	1	41	2.4390243902439	0.184762389447543	0.216307187645904	1	1	0.907423808073593	0.907423808073593	1
1513;	GO:0000422	autophagy of mitochondrion	1	41	2.4390243902439	0.184762389447543	0.216307187645904	1	1	0.907423808073593	0.907423808073593	1
1277; 1281; 1290; 1278; 2260; 4318; 1311; 10631; 165; 2134; 1303;	GO:0001501	skeletal system development	11	134	8.2089552238806	1.17101439656153e-10	2.24834764139814e-08	1.11948976311282e-07	1.12417382069907e-07	1.11948976311282e-07	1.11948976311282e-07	1.67382055436132e-07
4256; 1301; 4920;	GO:0001502	cartilage condensation	3	20	15	0.0001823698125063	0.00514926529429553	0.169239186005846	0.175075020006048	0.131488634817042	0.16905681619334	0.0383345792739219
1290; 4256; 6678; 1301; 4318; 7291;	GO:0001503	ossification	6	74	8.10810810810811	2.50647831889772e-06	0.000218747198740165	0.00238115440295283	0.00240621918614181	0.00237363496799614	0.00238115440295283	0.00162850064073081
5740;	GO:0001516	prostaglandin biosynthetic process	1	14	7.14285714285714	0.0703133638315967	0.112689197459654	1	1	0.907423808073593	0.907423808073593	0.838933852974602
348;	GO:0001523	retinoid metabolic process	1	61	1.63934426229508	0.260437620357342	0.287049501197529	1	1	0.907423808073593	0.907423808073593	1
2335; 347; 4313; 2260; 4240; 2191;	GO:0001525	angiogenesis	6	226	2.65486725663717	0.00093733067993429	0.0132329037167194	0.837036297181321	0.899837452736918	0.314005777777987	0.837036297181321	0.0985145972406448
2099;	GO:0001547	antral ovarian follicle growth	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
8839;	GO:0001558	regulation of cell growth	1	79	1.26582278481013	0.32257521705971	0.341424706038943	1	1	0.907423808073593	0.907423808073593	1
1277; 1278; 1289; 4016;	GO:0001568	blood vessel development	4	41	9.75609756097561	6.64638425242892e-05	0.00274631534156526	0.0623430842877832	0.0638052888233176	0.0596180667442874	0.0623430842877832	0.0204454105887789
6423;	GO:0001569	branching involved in blood vessel morphogenesis	1	30	3.33333333333333	0.139924021913819	0.174905027392274	1	1	0.907423808073593	0.907423808073593	1
1277; 1291; 10457; 7291; 6422; 22801;	GO:0001649	osteoblast differentiation	6	101	5.94059405940594	1.35678106749637e-05	0.000766182249880304	0.0128080132771657	0.0130250982479652	0.0126859029810911	0.0128080132771657	0.00570397377444243
2737;	GO:0001656	metanephros development	1	28	3.57142857142857	0.131513187863543	0.167443846616713	1	1	0.907423808073593	0.907423808073593	1
2260; 6422;	GO:0001657	ureteric bud development	2	38	5.26315789473684	0.0160958679392817	0.0623065855714132	1	1	0.799020555427036	0.907423808073593	0.463851949232596
2737;	GO:0001658	branching involved in ureteric bud morphogenesis	1	43	2.32558139534884	0.192662506247941	0.222838561443402	1	1	0.907423808073593	0.907423808073593	1
4313; 7043; 10631;	GO:0001666	response to hypoxia	3	157	1.91082802547771	0.0428971203644563	0.0872483804022839	1	1	0.907423808073593	0.907423808073593	0.649535373280902
4010; 2737; 7043; 2260; 2625; 7291;	GO:0001701	in utero embryonic development	6	171	3.50877192982456	0.000224148852897121	0.0053756132843422	0.206889391224043	0.215182898781237	0.149283136029483	0.206889391224043	0.0400196652953295
2625;	GO:0001709	cell fate determination	1	17	5.88235294117647	0.083777116024585	0.123923006754394	1	1	0.907423808073593	0.907423808073593	0.92256585255994
4920;	GO:0001756	somitogenesis	1	42	2.38095238095238	0.188721967914471	0.219337880384858	1	1	0.907423808073593	0.907423808073593	1
2260;	GO:0001759	organ induction	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
2260; 2625; 7291;	GO:0001764	neuron migration	3	103	2.9126213592233	0.0148715601986066	0.058994618969679	1	1	0.781810881925531	0.907423808073593	0.43919545185084
6363;	GO:0001768	establishment of T cell polarity	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
6363;	GO:0001771	immunological synapse formation	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
2625;	GO:0001806	type IV hypersensitivity	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
10457;	GO:0001818	negative regulation of cytokine production	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
1634; 2625; 5176; 23213;	GO:0001822	kidney development	4	84	4.76190476190476	0.000887118596292757	0.0129035432188037	0.793971143682018	0.851633852441047	0.305168797124709	0.793971143682018	0.0960626171239799
2625;	GO:0001823	mesonephros development	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
7291;	GO:0001843	neural tube closure	1	74	1.35135135135135	0.305852787818102	0.325880883801751	1	1	0.907423808073593	0.907423808073593	1
8406;	GO:0001845	phagolysosome assembly	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
716;	GO:0001867	complement activation, lectin pathway	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
1634;	GO:0001890	placenta development	1	36	2.77777777777778	0.164675692686062	0.198603850475652	1	1	0.907423808073593	0.907423808073593	1
2335;	GO:0001932	regulation of protein phosphorylation	1	37	2.7027027027027	0.168731846455733	0.202225433954437	1	1	0.907423808073593	0.907423808073593	1
2192;	GO:0001933	negative regulation of protein phosphorylation	1	66	1.51515151515152	0.27824297669269	0.302164318580297	1	1	0.907423808073593	0.907423808073593	1
4318; 10457;	GO:0001934	positive regulation of protein phosphorylation	2	138	1.44927536231884	0.14774255157288	0.18176761162025	1	1	0.907423808073593	0.907423808073593	1
348; 6678; 23213;	GO:0001937	negative regulation of endothelial cell proliferation	3	28	10.7142857142857	0.000450035680721328	0.00785516824531772	0.408632398094966	0.432034253492475	0.218121745549945	0.407732326733523	0.0584791329636324
7060;	GO:0001938	positive regulation of endothelial cell proliferation	1	70	1.42857142857143	0.2921811452629	0.315871508392324	1	1	0.907423808073593	0.907423808073593	1
10631;	GO:0001953	negative regulation of cell-matrix adhesion	1	18	5.55555555555556	0.0882219949067566	0.127358067835318	1	1	0.907423808073593	0.907423808073593	0.948138747680206
6422;	GO:0001954	positive regulation of cell-matrix adhesion	1	23	4.34782608695652	0.110128179209321	0.148696275725666	1	1	0.907423808073593	0.907423808073593	1
4313;	GO:0001955	blood vessel maturation	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
1277; 4313; 1513;	GO:0001957	intramembranous ossification	3	6	50	9.08743398408962e-06	0.000545246039045377	0.00858762511496469	0.00872393662472604	0.00856036281301242	0.00858762511496469	0.00405917666171373
1277;	GO:0001958	endochondral ossification	1	26	3.84615384615385	0.123020933257398	0.160462086857476	1	1	0.907423808073593	0.907423808073593	1
633;	GO:0001974	blood vessel remodeling	1	32	3.125	0.148254208227766	0.18176761162025	1	1	0.907423808073593	0.907423808073593	1
348;	GO:0002021	response to dietary excess	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
79570;	GO:0002028	regulation of sodium ion transport	1	19	5.26315789473684	0.0926455249139971	0.130601621024137	1	1	0.907423808073593	0.907423808073593	0.972285929800287
2737;	GO:0002052	positive regulation of neuroblast proliferation	1	20	5	0.0970478075547262	0.13502303659788	1	1	0.907423808073593	0.907423808073593	1
2260; 5396;	GO:0002053	positive regulation of mesenchymal cell proliferation	2	26	7.69230769230769	0.00809938985783121	0.0507325338260943	1	1	0.663981502762809	0.907423808073593	0.377686956987405
2260;	GO:0002062	chondrocyte differentiation	1	38	2.63157894736842	0.172768500433013	0.205778859076542	1	1	0.907423808073593	0.907423808073593	1
1301; 23213; 6423;	GO:0002063	chondrocyte development	3	14	21.4285714285714	7.15186286865954e-05	0.00274631534156526	0.0670129550793399	0.0686578835391316	0.0639376540458163	0.0669414364506533	0.0204454105887789
2099;	GO:0002064	epithelial cell development	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
2625;	GO:0002088	lens development in camera-type eye	1	33	3.03030303030303	0.152389298002329	0.186599140411015	1	1	0.907423808073593	0.907423808073593	1
6424;	GO:0002092	positive regulation of receptor internalization	1	23	4.34782608695652	0.110128179209321	0.148696275725666	1	1	0.907423808073593	0.907423808073593	1
1513;	GO:0002224	toll-like receptor signaling pathway	1	45	2.22222222222222	0.20048682463311	0.231053243274653	1	1	0.907423808073593	0.907423808073593	1
6422;	GO:0002244	hematopoietic progenitor cell differentiation	1	58	1.72413793103448	0.249546393809154	0.277595061479476	1	1	0.907423808073593	0.907423808073593	1
3956;	GO:0002317	plasma cell differentiation	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
6363;	GO:0002407	dendritic cell chemotaxis	1	17	5.88235294117647	0.083777116024585	0.123923006754394	1	1	0.907423808073593	0.907423808073593	0.92256585255994
6363;	GO:0002408	myeloid dendritic cell chemotaxis	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
26471;	GO:0002526	acute inflammatory response	1	17	5.88235294117647	0.083777116024585	0.123923006754394	1	1	0.907423808073593	0.907423808073593	0.92256585255994
6363;	GO:0002548	monocyte chemotaxis	1	43	2.32558139534884	0.192662506247941	0.222838561443402	1	1	0.907423808073593	0.907423808073593	1
2625;	GO:0002572	pro-T cell differentiation	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
3671; 2335; 6678; 7043;	GO:0002576	platelet degranulation	4	124	3.2258064516129	0.00350256299001761	0.0305678224583355	1	1	0.501847598371404	0.907423808073593	0.227567341414392
6363;	GO:0002606	positive regulation of dendritic cell antigen processing and presentation	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
1289;	GO:0003007	heart morphogenesis	1	31	3.2258064516129	0.144099148021041	0.178037557400514	1	1	0.907423808073593	0.907423808073593	1
10631;	GO:0003073	regulation of systemic arterial blood pressure	1	12	8.33333333333333	0.0612289019715984	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
23213;	GO:0003094	glomerular filtration	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
6423;	GO:0003151	outflow tract morphogenesis	1	42	2.38095238095238	0.188721967914471	0.219337880384858	1	1	0.907423808073593	0.907423808073593	1
2625; 7291;	GO:0003180	aortic valve morphogenesis	2	6	33.3333333333333	0.000639021504395654	0.0100047299011488	0.57639739696488	0.613460644219828	0.260720773793427	0.575119353956088	0.0744819094744729
7291;	GO:0003183	mitral valve morphogenesis	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
7291;	GO:0003203	endocardial cushion morphogenesis	1	16	6.25	0.0793107862791833	0.120092042315483	1	1	0.907423808073593	0.907423808073593	0.894045587709397
6423;	GO:0003214	cardiac left ventricle morphogenesis	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
2625;	GO:0003215	cardiac right ventricle morphogenesis	1	13	7.69230769230769	0.065782064732448	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
3776;	GO:0003231	cardiac ventricle development	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
7291;	GO:0003253	cardiac neural crest cell migration involved in outflow tract morphogenesis	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
2625;	GO:0003281	ventricular septum development	1	28	3.57142857142857	0.131513187863543	0.167443846616713	1	1	0.907423808073593	0.907423808073593	1
1311;	GO:0003417	growth plate cartilage development	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
347;	GO:0006006	glucose metabolic process	1	56	1.78571428571429	0.242197515010149	0.271306434550458	1	1	0.907423808073593	0.907423808073593	1
1301;	GO:0006029	proteoglycan metabolic process	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
5167;	GO:0006091	generation of precursor metabolites and energy	1	50	2	0.219720710746885	0.249623529369243	1	1	0.907423808073593	0.907423808073593	1
2099; 2625;	GO:0006338	chromatin remodeling	2	115	1.73913043478261	0.110451704047211	0.148923645906352	1	1	0.907423808073593	0.907423808073593	1
26471; 4010; 2099; 3223; 2260; 7291; 165; 29995; 11178;	GO:0006351	transcription, DNA-templated	9	1738	0.517836593785961	0.475430356385945	0.488665034400972	1	1	0.907423808073593	0.907423808073593	1
4010; 2099; 1382; 51450; 11178;	GO:0006355	regulation of transcription, DNA-templated	5	947	0.527983104540655	0.492446184469799	0.504533977685172	1	1	0.907423808073593	0.907423808073593	1
26471; 348; 2099; 3223; 51450;	GO:0006357	regulation of transcription by RNA polymerase II	5	1213	0.412201154163232	0.710490368238612	0.715709080282337	1	1	0.907423808073593	0.907423808073593	1
2099; 2737; 2625; 5396; 56917;	GO:0006366	transcription by RNA polymerase II	5	605	0.826446280991736	0.17445950645428	0.207535472361969	1	1	0.907423808073593	0.907423808073593	1
2099;	GO:0006367	transcription initiation from RNA polymerase II promoter	1	160	0.625	0.544032223817345	0.553839803674073	1	1	0.907423808073593	0.907423808073593	1
2260;	GO:0006468	protein phosphorylation	1	464	0.21551724137931	0.898249202877279	0.899185854809373	1	1	0.907423808073593	0.907423808073593	1
1634; 633; 127435; 146760; 131578;	GO:0006469	negative regulation of protein kinase activity	5	104	4.80769230769231	0.000189677827374668	0.00520259183656232	0.175641668148943	0.182090714279681	0.134860935263389	0.175641668148943	0.0387315777669292
26471;	GO:0006473	protein acetylation	1	13	7.69230769230769	0.065782064732448	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
2134;	GO:0006486	protein glycosylation	1	87	1.14942528735632	0.348505276646809	0.365245704782682	1	1	0.907423808073593	0.907423808073593	1
146760;	GO:0006501	C-terminal protein lipidation	1	73	1.36986301369863	0.302459586409567	0.323702567394854	1	1	0.907423808073593	0.907423808073593	1
8038; 4313; 716; 4318; 4320; 1513; 2191; 5118; 6422;	GO:0006508	proteolysis	9	508	1.77165354330709	0.000917963193818094	0.0131529054636622	0.820659095273376	0.881244666065371	0.310271559510516	0.820659095273376	0.0979190366706755
23194;	GO:0006511	ubiquitin-dependent protein catabolic process	1	218	0.458715596330275	0.656911256848908	0.66382611218416	1	1	0.907423808073593	0.907423808073593	1
165; 119587;	GO:0006518	peptide metabolic process	2	13	15.3846153846154	0.00234387734465391	0.0234387734465391	1	1	0.443603280041521	0.907423808073593	0.174493926301533
347;	GO:0006629	lipid metabolic process	1	142	0.704225352112676	0.50203479477188	0.512716386150005	1	1	0.907423808073593	0.907423808073593	1
54898;	GO:0006636	unsaturated fatty acid biosynthetic process	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
348;	GO:0006641	triglyceride metabolic process	1	35	2.85714285714286	0.160599945882917	0.194666601070202	1	1	0.907423808073593	0.907423808073593	1
340075;	GO:0006687	glycosphingolipid metabolic process	1	48	2.08333333333333	0.212082753283378	0.242380289466718	1	1	0.907423808073593	0.907423808073593	1
5740;	GO:0006690	icosanoid metabolic process	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
348;	GO:0006695	cholesterol biosynthetic process	1	41	2.4390243902439	0.184762389447543	0.216307187645904	1	1	0.907423808073593	0.907423808073593	1
348;	GO:0006707	cholesterol catabolic process	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
5167;	GO:0006771	riboflavin metabolic process	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
5167;	GO:0006796	phosphate-containing compound metabolic process	1	19	5.26315789473684	0.0926455249139971	0.130601621024137	1	1	0.907423808073593	0.907423808073593	0.972285929800287
347;	GO:0006869	lipid transport	1	73	1.36986301369863	0.302459586409567	0.323702567394854	1	1	0.907423808073593	0.907423808073593	1
348; 6363;	GO:0006874	cellular calcium ion homeostasis	2	88	2.27272727272727	0.0707849214772189	0.11325587436355	1	1	0.907423808073593	0.907423808073593	0.843152575346349
348; 6678; 5167; 81035;	GO:0006898	receptor-mediated endocytosis	4	196	2.04081632653061	0.0163250500477895	0.0629399519914776	1	1	0.799927452341686	0.907423808073593	0.468567153024153
4240; 81035;	GO:0006910	phagocytosis, recognition	2	84	2.38095238095238	0.0653972728249461	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
4240;	GO:0006911	phagocytosis, engulfment	1	100	1	0.388561550339369	0.405455530788907	1	1	0.907423808073593	0.907423808073593	1
8406;	GO:0006914	autophagy	1	118	0.847457627118644	0.440027880042395	0.454711264629386	1	1	0.907423808073593	0.907423808073593	1
3956; 1311; 23213; 6423;	GO:0006915	apoptotic process	4	540	0.740740740740741	0.270735443410725	0.295153569494005	1	1	0.907423808073593	0.907423808073593	1
22801;	GO:0006929	substrate-dependent cell migration	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
10398; 59;	GO:0006936	muscle contraction	2	105	1.9047619047619	0.095153334220065	0.133940177201265	1	1	0.907423808073593	0.907423808073593	0.997140377788104
10398;	GO:0006937	regulation of muscle contraction	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
2625; 81035;	GO:0006952	defense response	2	65	3.07692307692308	0.0419482268192972	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
2335;	GO:0006953	acute-phase response	1	37	2.7027027027027	0.168731846455733	0.202225433954437	1	1	0.907423808073593	0.907423808073593	1
6363;	GO:0006954	inflammatory response	1	391	0.255754475703325	0.853831985224478	0.85561451546503	1	1	0.907423808073593	0.907423808073593	1
715; 5167; 6363;	GO:0006955	immune response	3	439	0.683371298405467	0.362293589399655	0.378869113097679	1	1	0.907423808073593	0.907423808073593	1
715; 716;	GO:0006956	complement activation	2	91	2.1978021978022	0.0749176435942357	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
715; 716;	GO:0006958	complement activation, classical pathway	2	149	1.34228187919463	0.166382305838487	0.20041030565238	1	1	0.907423808073593	0.907423808073593	1
2625;	GO:0006959	humoral immune response	1	57	1.75438596491228	0.245880816677305	0.274471609314201	1	1	0.907423808073593	0.907423808073593	1
7060;	GO:0006986	response to unfolded protein	1	50	2	0.219720710746885	0.249623529369243	1	1	0.907423808073593	0.907423808073593	1
348;	GO:0007010	cytoskeleton organization	1	160	0.625	0.544032223817345	0.553839803674073	1	1	0.907423808073593	0.907423808073593	1
2335;	GO:0007044	cell-substrate junction assembly	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
2619;	GO:0007050	cell cycle arrest	1	140	0.714285714285714	0.497138290816477	0.508256399556781	1	1	0.907423808073593	0.907423808073593	1
83987;	GO:0007088	regulation of mitotic nuclear division	1	22	4.54545454545455	0.105789034383918	0.144257774159888	1	1	0.907423808073593	0.907423808073593	1
6363;	GO:0007154	cell communication	1	28	3.57142857142857	0.131513187863543	0.167443846616713	1	1	0.907423808073593	0.907423808073593	1
3671; 8038; 8839; 2335; 1291; 1292; 1293; 1289; 1311; 8406; 1805; 4240; 2191; 10457; 10631; 1303; 22801; 11117;	GO:0007155	cell adhesion	18	464	3.87931034482759	1.69132485794421e-11	4.0591796590661e-09	1.61859788905261e-08	1.62367186362644e-08	1.61859788905261e-08	1.61859788905261e-08	3.02192517833458e-08
1281; 22801; 11117;	GO:0007160	cell-matrix adhesion	3	93	3.2258064516129	0.0114020285517845	0.0565278343254897	1	1	0.729729827314209	0.907423808073593	0.420831054972876
2335;	GO:0007161	calcium-independent cell-matrix adhesion	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
2192;	GO:0007162	negative regulation of cell adhesion	1	43	2.32558139534884	0.192662506247941	0.222838561443402	1	1	0.907423808073593	0.907423808073593	1
8839; 148252; 2099; 3956; 6678; 2625; 1382; 4920; 10457; 57758;	GO:0007165	signal transduction	10	1201	0.832639467110741	0.0687001701108872	0.112163543038183	1	1	0.907423808073593	0.907423808073593	0.835020529434468
4920;	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	1	105	0.952380952380952	0.403309949714651	0.419477304145249	1	1	0.907423808073593	0.907423808073593	1
1281; 1278; 7043;	GO:0007179	transforming growth factor beta receptor signaling pathway	3	90	3.33333333333333	0.0104637555395752	0.0533085083945616	1	1	0.711215959260163	0.907423808073593	0.396864236785343
3776; 348; 5157; 6424; 6422; 6423; 6363;	GO:0007186	G-protein coupled receptor signaling pathway	7	1130	0.619469026548673	0.313243151638418	0.333015975163766	1	1	0.907423808073593	0.907423808073593	1
2099;	GO:0007200	phospholipase C-activating G-protein coupled receptor signaling pathway	1	65	1.53846153846154	0.274716189381115	0.298672187775618	1	1	0.907423808073593	0.907423808073593	1
2099;	GO:0007204	positive regulation of cytosolic calcium ion concentration	1	137	0.72992700729927	0.489704026648569	0.502260540152378	1	1	0.907423808073593	0.907423808073593	1
4920;	GO:0007223	Wnt signaling pathway, calcium modulating pathway	1	37	2.7027027027027	0.168731846455733	0.202225433954437	1	1	0.907423808073593	0.907423808073593	1
2737; 4920;	GO:0007224	smoothened signaling pathway	2	64	3.125	0.0408222604216388	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
1281; 2192; 22801;	GO:0007229	integrin-mediated signaling pathway	3	87	3.44827586206897	0.00957215233244124	0.0507325338260943	1	1	0.691481887138627	0.907423808073593	0.377686956987405
4920;	GO:0007254	JNK cascade	1	48	2.08333333333333	0.212082753283378	0.242380289466718	1	1	0.907423808073593	0.907423808073593	1
6363;	GO:0007257	activation of JUN kinase activity	1	36	2.77777777777778	0.164675692686062	0.198603850475652	1	1	0.907423808073593	0.907423808073593	1
348;	GO:0007263	nitric oxide mediated signal transduction	1	18	5.55555555555556	0.0882219949067566	0.127358067835318	1	1	0.907423808073593	0.907423808073593	0.948138747680206
1278;	GO:0007266	Rho protein signal transduction	1	80	1.25	0.325871527618377	0.344533773693438	1	1	0.907423808073593	0.907423808073593	1
8839; 10457; 6423;	GO:0007267	cell-cell signaling	3	316	0.949367088607595	0.201637642604881	0.232100883573964	1	1	0.907423808073593	0.907423808073593	1
348;	GO:0007271	synaptic transmission, cholinergic	1	29	3.44827586206897	0.135728733985959	0.170549194537331	1	1	0.907423808073593	0.907423808073593	1
4010; 3223; 4320; 5176; 4920; 5118; 51450; 57758; 56944; 2260;	GO:0007275	multicellular organism development	10	568	1.76056338028169	0.000497579844238927	0.00852994018695303	0.450309759036229	0.47767665046937	0.231374627571101	0.450309759036229	0.0635025871867219
4240;	GO:0007338	single fertilization	1	58	1.72413793103448	0.249546393809154	0.277595061479476	1	1	0.907423808073593	0.907423808073593	1
4060;	GO:0007409	axonogenesis	1	102	0.980392156862745	0.394503724086238	0.41076309666246	1	1	0.907423808073593	0.907423808073593	1
2737; 2625;	GO:0007411	axon guidance	2	191	1.04712041884817	0.240343087083458	0.269858904795462	1	1	0.907423808073593	0.907423808073593	1
7077; 2260;	GO:0007417	central nervous system development	2	118	1.69491525423729	0.115161059278976	0.153548079038635	1	1	0.907423808073593	0.907423808073593	1
347;	GO:0007420	brain development	1	201	0.497512437810945	0.62705115012789	0.634988506458623	1	1	0.907423808073593	0.907423808073593	1
7043;	GO:0007435	salivary gland morphogenesis	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
2737;	GO:0007442	hindgut morphogenesis	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
1281; 6678; 2737; 2625;	GO:0007507	heart development	4	188	2.12765957446809	0.0142569089577451	0.0581497223322038	1	1	0.771736926705138	0.907423808073593	0.432905475460724
1293; 6876; 7291; 165; 22801;	GO:0007517	muscle organ development	5	90	5.55555555555556	9.9235239227724e-05	0.00366407037148519	0.092784948677922	0.0952658296586151	0.0852038307559048	0.092784948677922	0.0272777936449561
1634;	GO:0007519	skeletal muscle tissue development	1	47	2.12765957446809	0.208236064581996	0.238837063319852	1	1	0.907423808073593	0.907423808073593	1
8038;	GO:0007520	myoblast fusion	1	20	5	0.0970478075547262	0.13502303659788	1	1	0.907423808073593	0.907423808073593	1
7043;	GO:0007565	female pregnancy	1	87	1.14942528735632	0.348505276646809	0.365245704782682	1	1	0.907423808073593	0.907423808073593	1
4313; 4318; 2192; 5740;	GO:0007566	embryo implantation	4	38	10.5263157894737	5.04891243463534e-05	0.0023080742558333	0.0474597768855722	0.0484695593724993	0.0458441249064889	0.0474597768855722	0.0171828504599207
1281; 347; 1634; 7043; 7077; 5176;	GO:0007568	aging	6	154	3.8961038961039	0.000129450339072412	0.00416038430799737	0.120647716015488	0.124272325509516	0.103811119036693	0.120647716015488	0.0309726869659616
6423;	GO:0007584	response to nutrient	1	62	1.61290322580645	0.264033139729474	0.290345720664713	1	1	0.907423808073593	0.907423808073593	1
1277; 1278; 2625;	GO:0007596	blood coagulation	3	171	1.75438596491228	0.0526813200460893	0.0965153955042857	1	1	0.907423808073593	0.907423808073593	0.718525239748623
1277; 1301; 4060;	GO:0007601	visual perception	3	197	1.52284263959391	0.0734157075798881	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
1277; 2260; 1301;	GO:0007605	sensory perception of sound	3	136	2.20588235294118	0.0301357200929631	0.0757337468304831	1	1	0.8855758114244	0.907423808073593	0.563812729711273
3776;	GO:0007613	memory	1	72	1.38888888888889	0.299049964679206	0.321127478850154	1	1	0.907423808073593	0.907423808073593	1
5176;	GO:0007614	short-term memory	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
348;	GO:0007616	long-term memory	1	35	2.85714285714286	0.160599945882917	0.194666601070202	1	1	0.907423808073593	0.907423808073593	1
633; 5157; 57124;	GO:0008150	biological_process	3	611	0.490998363338789	0.575294799907466	0.583808676438866	1	1	0.907423808073593	0.907423808073593	1
348;	GO:0008203	cholesterol metabolic process	1	64	1.5625	0.271172341972617	0.295153569494005	1	1	0.907423808073593	0.907423808073593	1
2099;	GO:0008209	androgen metabolic process	1	15	6.66666666666667	0.0748229031998671	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
1278; 59;	GO:0008217	regulation of blood pressure	2	65	3.07692307692308	0.0419482268192972	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
26471; 5176; 23194;	GO:0008283	cell proliferation	3	365	0.821917808219178	0.2643397641185	0.290350312990572	1	1	0.907423808073593	0.907423808073593	1
2335; 7043; 2260; 6422; 6423; 57124;	GO:0008284	positive regulation of cell proliferation	6	477	1.25786163522013	0.0301244983094877	0.0757337468304831	1	1	0.8855758114244	0.907423808073593	0.563812729711273
2737; 7043; 7077; 2625; 4920; 1805; 10457; 6424; 127435; 6422; 6423;	GO:0008285	negative regulation of cell proliferation	11	391	2.81329923273657	4.01827932039467e-06	0.000275539153398492	0.00380531051641375	0.00385754814757888	0.00380129223709336	0.00380531051641375	0.00205129798434067
2335;	GO:0008360	regulation of cell shape	1	159	0.628930817610063	0.5417939057366	0.552733421367838	1	1	0.907423808073593	0.907423808073593	1
2260;	GO:0008543	fibroblast growth factor receptor signaling pathway	1	82	1.21951219512195	0.332416584360569	0.350681231852907	1	1	0.907423808073593	0.907423808073593	1
1382;	GO:0008544	epidermis development	1	82	1.21951219512195	0.332416584360569	0.350681231852907	1	1	0.907423808073593	0.907423808073593	1
26471; 2099; 2625; 6422; 6423;	GO:0008584	male gonad development	5	92	5.43478260869565	0.000109537208073718	0.00389465628706552	0.102307752340852	0.105155719750769	0.0915731059496281	0.102307752340852	0.0289944296221423
6422;	GO:0008585	female gonad development	1	19	5.26315789473684	0.0926455249139971	0.130601621024137	1	1	0.907423808073593	0.907423808073593	0.972285929800287
2619;	GO:0008589	regulation of smoothened signaling pathway	1	18	5.55555555555556	0.0882219949067566	0.127358067835318	1	1	0.907423808073593	0.907423808073593	0.948138747680206
10631;	GO:0008593	regulation of Notch signaling pathway	1	13	7.69230769230769	0.065782064732448	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
5167;	GO:0009143	nucleoside triphosphate catabolic process	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
6422;	GO:0009267	cellular response to starvation	1	63	1.58730158730159	0.267611352780174	0.292938310911023	1	1	0.907423808073593	0.907423808073593	1
1281;	GO:0009314	response to radiation	1	29	3.44827586206897	0.135728733985959	0.170549194537331	1	1	0.907423808073593	0.907423808073593	1
2335;	GO:0009611	response to wounding	1	64	1.5625	0.271172341972617	0.295153569494005	1	1	0.907423808073593	0.907423808073593	1
3776; 1281; 1634; 10631;	GO:0009612	response to mechanical stimulus	4	60	6.66666666666667	0.000264148445873191	0.00589726762879683	0.24248827331159	0.253582508038264	0.164564481778998	0.24248827331159	0.0439032095833341
2625; 59; 6363;	GO:0009615	response to virus	3	106	2.83018867924528	0.016016191064703	0.0623065855714132	1	1	0.799020555427036	0.907423808073593	0.463851949232596
6678;	GO:0009629	response to gravity	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
26471;	GO:0009636	response to toxic substance	1	74	1.35135135135135	0.305852787818102	0.325880883801751	1	1	0.907423808073593	0.907423808073593	1
2625;	GO:0009653	anatomical structure morphogenesis	1	139	0.719424460431655	0.494672194454355	0.50627431415371	1	1	0.907423808073593	0.907423808073593	1
7077; 6424;	GO:0009725	response to hormone	2	43	4.65116279069767	0.0201125974456863	0.065451164569013	1	1	0.837706848644703	0.907423808073593	0.487262301190989
1292;	GO:0009749	response to glucose	1	72	1.38888888888889	0.299049964679206	0.321127478850154	1	1	0.907423808073593	0.907423808073593	1
81035;	GO:0009756	carbohydrate mediated signaling	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
2625;	GO:0009791	post-embryonic development	1	71	1.40845070422535	0.295623843972797	0.318875157543691	1	1	0.907423808073593	0.907423808073593	1
1634; 1311; 2625;	GO:0009887	animal organ morphogenesis	3	91	3.2967032967033	0.0107713064709034	0.0544234432214067	1	1	0.715666622334382	0.907423808073593	0.405164558299618
2625;	GO:0009888	tissue development	1	22	4.54545454545455	0.105789034383918	0.144257774159888	1	1	0.907423808073593	0.907423808073593	1
6422;	GO:0009950	dorsal/ventral axis specification	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
3223; 2737;	GO:0009952	anterior/posterior pattern specification	2	80	2.5	0.0601566552929694	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
4010;	GO:0009953	dorsal/ventral pattern formation	1	31	3.2258064516129	0.144099148021041	0.178037557400514	1	1	0.907423808073593	0.907423808073593	1
2737;	GO:0009954	proximal/distal pattern formation	1	23	4.34782608695652	0.110128179209321	0.148696275725666	1	1	0.907423808073593	0.907423808073593	1
2625;	GO:0009967	positive regulation of signal transduction	1	59	1.69491525423729	0.253194330840938	0.280030596321775	1	1	0.907423808073593	0.907423808073593	1
2260; 4920;	GO:0009968	negative regulation of signal transduction	2	93	2.1505376344086	0.0777148833792574	0.119945800713966	1	1	0.907423808073593	0.907423808073593	0.892956867290839
7077;	GO:0010033	response to organic substance	1	40	2.5	0.180783679781611	0.213734399741807	1	1	0.907423808073593	0.907423808073593	1
23194;	GO:0010265	SCF complex assembly	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
6678;	GO:0010288	response to lead ion	1	18	5.55555555555556	0.0882219949067566	0.127358067835318	1	1	0.907423808073593	0.907423808073593	0.948138747680206
2625;	GO:0010332	response to gamma radiation	1	28	3.57142857142857	0.131513187863543	0.167443846616713	1	1	0.907423808073593	0.907423808073593	1
5176;	GO:0010447	response to acidic pH	1	12	8.33333333333333	0.0612289019715984	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
7043; 7060; 10457; 6423; 6363;	GO:0010469	regulation of signaling receptor activity	5	440	1.13636363636364	0.0653566974104828	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
1634;	GO:0010508	positive regulation of autophagy	1	41	2.4390243902439	0.184762389447543	0.216307187645904	1	1	0.907423808073593	0.907423808073593	1
2260;	GO:0010518	positive regulation of phospholipase activity	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
348;	GO:0010544	negative regulation of platelet activation	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
6363;	GO:0010560	positive regulation of glycoprotein biosynthetic process	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
6422;	GO:0010564	regulation of cell cycle process	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
23213;	GO:0010575	positive regulation of vascular endothelial growth factor production	1	27	3.7037037037037	0.127277286716657	0.164449791720041	1	1	0.907423808073593	0.907423808073593	1
6678; 2625;	GO:0010595	positive regulation of endothelial cell migration	2	46	4.34782608695652	0.0227026292174961	0.0671828519880796	1	1	0.849794970558768	0.907423808073593	0.500154142036207
1634; 5176;	GO:0010596	negative regulation of endothelial cell migration	2	20	10	0.00504394515129392	0.0410354859766285	1	1	0.569965802096213	0.907423808073593	0.305495638757953
29995;	GO:0010611	regulation of cardiac muscle hypertrophy	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
2335; 59; 7291; 6424;	GO:0010628	positive regulation of gene expression	4	298	1.34228187919463	0.0593602822036265	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
348; 2099; 5176; 6422; 6423;	GO:0010629	negative regulation of gene expression	5	160	3.125	0.00125762542625862	0.0158857948580037	1	1	0.355907995631191	0.907423808073593	0.118264495517067
347;	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
6423;	GO:0010667	negative regulation of cardiac muscle cell apoptotic process	1	19	5.26315789473684	0.0926455249139971	0.130601621024137	1	1	0.907423808073593	0.907423808073593	0.972285929800287
2191;	GO:0010710	regulation of collagen catabolic process	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
2191;	GO:0010716	negative regulation of extracellular matrix disassembly	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
1277; 7043; 7291;	GO:0010718	positive regulation of epithelial to mesenchymal transition	3	42	7.14285714285714	0.00135259540269728	0.0166473280331972	1	1	0.367905949533659	0.907423808073593	0.123933858466092
6422; 6423;	GO:0010719	negative regulation of epithelial to mesenchymal transition	2	24	8.33333333333333	0.00700768317153899	0.0507325338260943	1	1	0.641488904430735	0.907423808073593	0.377686956987405
2199; 11117;	GO:0010811	positive regulation of cell-substrate adhesion	2	37	5.40540540540541	0.0153389953185231	0.060598500023795	1	1	0.787245515662849	0.907423808073593	0.451135816524431
1277; 3956;	GO:0010812	negative regulation of cell-substrate adhesion	2	15	13.3333333333333	0.00301677393088262	0.0273217261664841	1	1	0.480696933305943	0.907423808073593	0.203401226732242
7043;	GO:0010862	positive regulation of pathway-restricted SMAD protein phosphorylation	1	48	2.08333333333333	0.212082753283378	0.242380289466718	1	1	0.907423808073593	0.907423808073593	1
2099; 2260;	GO:0010863	positive regulation of phospholipase C activity	2	9	22.2222222222222	0.00124336246840029	0.0158857948580037	1	1	0.354250414713956	0.907423808073593	0.118264495517067
348;	GO:0010873	positive regulation of cholesterol esterification	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
348;	GO:0010875	positive regulation of cholesterol efflux	1	15	6.66666666666667	0.0748229031998671	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
348;	GO:0010877	lipid transport involved in lipid storage	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
83987;	GO:0010923	negative regulation of phosphatase activity	1	55	1.81818181818182	0.238496403972345	0.268099002123479	1	1	0.907423808073593	0.907423808073593	1
7043;	GO:0010936	negative regulation of macrophage cytokine production	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
3776;	GO:0010942	positive regulation of cell death	1	36	2.77777777777778	0.164675692686062	0.198603850475652	1	1	0.907423808073593	0.907423808073593	1
6423;	GO:0010950	positive regulation of endopeptidase activity	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
1293; 7077; 5176;	GO:0010951	negative regulation of endopeptidase activity	3	123	2.4390243902439	0.0234190692350867	0.0671828519880796	1	1	0.853289193299553	0.907423808073593	0.500154142036207
2335; 2192; 5118;	GO:0010952	positive regulation of peptidase activity	3	14	21.4285714285714	7.15186286865954e-05	0.00274631534156526	0.0670129550793399	0.0686578835391316	0.0639376540458163	0.0669414364506533	0.0204454105887789
2619;	GO:0010955	negative regulation of protein processing	1	13	7.69230769230769	0.065782064732448	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
2260;	GO:0010966	regulation of phosphate transport	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
23194;	GO:0010972	negative regulation of G2/M transition of mitotic cell cycle	1	59	1.69491525423729	0.253194330840938	0.280030596321775	1	1	0.907423808073593	0.907423808073593	1
2625; 6422; 6423;	GO:0010975	regulation of neuron projection development	3	20	15	0.0001823698125063	0.00514926529429553	0.169239186005846	0.175075020006048	0.131488634817042	0.16905681619334	0.0383345792739219
348; 2260; 5176;	GO:0010976	positive regulation of neuron projection development	3	95	3.15789473684211	0.0120536755465607	0.0581497223322038	1	1	0.741098982758489	0.907423808073593	0.432905475460724
348; 7431; 3956; 146760;	GO:0010977	negative regulation of neuron projection development	4	57	7.01754385964912	0.000219378125008718	0.0053756132843422	0.202924765633064	0.210603000008369	0.147422100005858	0.202705387508055	0.0400196652953295
7431; 4920;	GO:0014002	astrocyte development	2	17	11.7647058823529	0.0037692961461091	0.0323082526809352	1	1	0.513389493554976	0.907423808073593	0.240524269544098
347;	GO:0014012	peripheral nervous system axon regeneration	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
6422;	GO:0014034	neural crest cell fate commitment	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
2625;	GO:0014065	phosphatidylinositol 3-kinase signaling	1	31	3.2258064516129	0.144099148021041	0.178037557400514	1	1	0.907423808073593	0.907423808073593	1
7291;	GO:0014067	negative regulation of phosphatidylinositol 3-kinase signaling	1	12	8.33333333333333	0.0612289019715984	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
1634; 2260;	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	2	67	2.98507462686567	0.044234861726416	0.0895895933699564	1	1	0.907423808073593	0.907423808073593	0.666964930504494
4060; 6422;	GO:0014070	response to organic cyclic compound	2	43	4.65116279069767	0.0201125974456863	0.065451164569013	1	1	0.837706848644703	0.907423808073593	0.487262301190989
59;	GO:0014829	vascular smooth muscle contraction	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
23213;	GO:0014846	esophagus smooth muscle contraction	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
10631;	GO:0014850	response to muscle activity	1	20	5	0.0970478075547262	0.13502303659788	1	1	0.907423808073593	0.907423808073593	1
10631;	GO:0014911	positive regulation of smooth muscle cell migration	1	18	5.55555555555556	0.0882219949067566	0.127358067835318	1	1	0.907423808073593	0.907423808073593	0.948138747680206
1277;	GO:0015031	protein transport	1	365	0.273972602739726	0.833756435310558	0.836370091847582	1	1	0.907423808073593	0.907423808073593	1
348;	GO:0015909	long-chain fatty acid transport	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
7431; 2192; 4240;	GO:0016032	viral process	3	333	0.900900900900901	0.223011552998044	0.253062755175086	1	1	0.907423808073593	0.907423808073593	1
1634;	GO:0016239	positive regulation of macroautophagy	1	30	3.33333333333333	0.139924021913819	0.174905027392274	1	1	0.907423808073593	0.907423808073593	1
11178;	GO:0016242	negative regulation of macroautophagy	1	14	7.14285714285714	0.0703133638315967	0.112689197459654	1	1	0.907423808073593	0.907423808073593	0.838933852974602
2260; 1289; 115908; 57124; 11117;	GO:0016477	cell migration	5	211	2.3696682464455	0.00404375879317675	0.0337565951430407	1	1	0.525688643112978	0.907423808073593	0.251306700775769
2737; 165; 119587;	GO:0016485	protein processing	3	66	4.54545454545455	0.00459244247037771	0.0380064204445052	1	1	0.550271489442329	0.907423808073593	0.282945246395042
1634; 6678; 7060; 5176; 23213;	GO:0016525	negative regulation of angiogenesis	5	76	6.57894736842105	4.6294598312957e-05	0.00222214071902194	0.0435632170124925	0.0444428143804387	0.0421280844647909	0.0435632170124925	0.0165431036628712
23194;	GO:0016567	protein ubiquitination	1	483	0.20703933747412	0.907423808073593	0.907423808073593	1	1	0.907423808073593	0.907423808073593	1
2099; 2625;	GO:0016579	protein deubiquitination	2	270	0.740740740740741	0.380690181622803	0.397674183196834	1	1	0.907423808073593	0.907423808073593	1
348;	GO:0017038	protein import	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
2260; 4920;	GO:0018108	peptidyl-tyrosine phosphorylation	2	155	1.29032258064516	0.176717114715189	0.209265496329524	1	1	0.907423808073593	0.907423808073593	1
4060;	GO:0018146	keratan sulfate biosynthetic process	1	29	3.44827586206897	0.135728733985959	0.170549194537331	1	1	0.907423808073593	0.907423808073593	1
1281; 2335;	GO:0018149	peptide cross-linking	2	51	3.92156862745098	0.0273054983965404	0.0725955692646671	1	1	0.873775948689293	0.907423808073593	0.540450034298067
4016;	GO:0018277	protein deamination	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
348;	GO:0019068	virion assembly	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
2335; 1634; 1278; 4313; 7431; 4318; 633; 2625; 7291; 127435; 146760; 131578; 6363;	GO:0019221	cytokine-mediated signaling pathway	13	310	4.19354838709677	5.5930762243861e-09	8.94892195901775e-07	5.34138779428872e-06	5.36935317541065e-06	5.34138779428872e-06	5.34138779428872e-06	6.66217680868275e-06
54898;	GO:0019367	fatty acid elongation, saturated fatty acid	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
5740;	GO:0019371	cyclooxygenase pathway	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
348;	GO:0019433	triglyceride catabolic process	1	26	3.84615384615385	0.123020933257398	0.160462086857476	1	1	0.907423808073593	0.907423808073593	1
1634; 633;	GO:0019800	peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan	2	6	33.3333333333333	0.000639021504395654	0.0100047299011488	0.57639739696488	0.613460644219828	0.260720773793427	0.575119353956088	0.0744819094744729
348;	GO:0019934	cGMP-mediated signaling	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
2737;	GO:0021631	optic nerve morphogenesis	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
2737;	GO:0021766	hippocampus development	1	57	1.75438596491228	0.245880816677305	0.274471609314201	1	1	0.907423808073593	0.907423808073593	1
2737;	GO:0021775	smoothened signaling pathway involved in ventral spinal cord interneuron specification	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
2737;	GO:0021776	smoothened signaling pathway involved in spinal cord motor neuron cell fate specification	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
2737;	GO:0021798	forebrain dorsal/ventral pattern formation	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
2737;	GO:0021819	layer formation in cerebral cortex	1	12	8.33333333333333	0.0612289019715984	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
2260;	GO:0021847	ventricular zone neuroblast division	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
2737;	GO:0021861	forebrain radial glial cell differentiation	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
1281;	GO:0021987	cerebral cortex development	1	59	1.69491525423729	0.253194330840938	0.280030596321775	1	1	0.907423808073593	0.907423808073593	1
2737;	GO:0022018	lateral ganglionic eminence cell proliferation	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
146760;	GO:0022038	corpus callosum development	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
6678;	GO:0022604	regulation of cell morphogenesis	1	27	3.7037037037037	0.127277286716657	0.164449791720041	1	1	0.907423808073593	0.907423808073593	1
2335; 1634; 4313; 4318; 7077; 4320; 1513;	GO:0022617	extracellular matrix disassembly	7	80	8.75	2.1626030466404e-07	2.59512365596848e-05	0.00020609607034483	0.000207609892477478	0.000205879810040166	0.00020609607034483	0.000193198384292926
7431;	GO:0030049	muscle filament sliding	1	38	2.63157894736842	0.172768500433013	0.205778859076542	1	1	0.907423808073593	0.907423808073593	1
2099;	GO:0030111	regulation of Wnt signaling pathway	1	25	4	0.118744029737539	0.156370738749023	1	1	0.907423808073593	0.907423808073593	1
54898;	GO:0030148	sphingolipid biosynthetic process	1	52	1.92307692307692	0.227285360241388	0.257607964382211	1	1	0.907423808073593	0.907423808073593	1
4256; 6424; 57758; 4920; 2260;	GO:0030154	cell differentiation	5	617	0.810372771474878	0.184244872450763	0.216307187645904	1	1	0.907423808073593	0.907423808073593	1
1277; 1281; 1278;	GO:0030168	platelet activation	3	111	2.7027027027027	0.0180313665050775	0.0638195406695263	1	1	0.826523709605657	0.907423808073593	0.47511540019729
23213; 6422;	GO:0030177	positive regulation of Wnt signaling pathway	2	36	5.55555555555556	0.0145980032104803	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
6424; 6422; 6423;	GO:0030178	negative regulation of Wnt signaling pathway	3	49	6.12244897959184	0.00205558384649995	0.0216852801389006	1	1	0.426962280980974	0.907423808073593	0.161439747818551
4010;	GO:0030182	neuron differentiation	1	107	0.934579439252336	0.409110202546929	0.425049561087718	1	1	0.907423808073593	0.907423808073593	1
348;	GO:0030195	negative regulation of blood coagulation	1	14	7.14285714285714	0.0703133638315967	0.112689197459654	1	1	0.907423808073593	0.907423808073593	0.838933852974602
8038; 1277; 1281; 2335; 1290; 1634; 1278; 6678; 1301; 1291; 1292; 1293; 1289; 633; 2192; 7060; 1311; 4060; 4237; 2199; 4016; 8076; 10631; 22801; 11117;	GO:0030198	extracellular matrix organization	25	197	12.6903553299492	1.93955962402015e-13	6.20659079686448e-11	1.8580981198113e-10	1.86197723905934e-10	1.8580981198113e-10	1.8580981198113e-10	4.62060183977656e-10
1277; 1281; 1290; 1278; 1301; 1289; 4320; 4060; 1805; 6423; 1303; 4016;	GO:0030199	collagen fibril organization	12	42	28.5714285714286	0	0	0	0	0	0	0
23213;	GO:0030201	heparan sulfate proteoglycan metabolic process	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
1634; 633;	GO:0030203	glycosaminoglycan metabolic process	2	29	6.89655172413793	0.00987009615082413	0.0512177962421144	1	1	0.6989111848785	0.907423808073593	0.38129957538875
1634; 633;	GO:0030206	chondroitin sulfate biosynthetic process	2	25	8	0.00754453822179602	0.0507325338260943	1	1	0.651895927539605	0.907423808073593	0.377686956987405
1634; 633;	GO:0030207	chondroitin sulfate catabolic process	2	14	14.2857142857143	0.00267027330709002	0.0248879842214216	1	1	0.461957282126574	0.907423808073593	0.185282821835018
1634; 633;	GO:0030208	dermatan sulfate biosynthetic process	2	12	16.6666666666667	0.00203778608079697	0.0216852801389006	1	1	0.425897290886566	0.907423808073593	0.161439747818551
2625;	GO:0030218	erythrocyte differentiation	1	41	2.4390243902439	0.184762389447543	0.216307187645904	1	1	0.907423808073593	0.907423808073593	1
4318;	GO:0030225	macrophage differentiation	1	18	5.55555555555556	0.0882219949067566	0.127358067835318	1	1	0.907423808073593	0.907423808073593	0.948138747680206
6422;	GO:0030279	negative regulation of ossification	1	18	5.55555555555556	0.0882219949067566	0.127358067835318	1	1	0.907423808073593	0.907423808073593	0.948138747680206
4920; 10457;	GO:0030282	bone mineralization	2	36	5.55555555555556	0.0145980032104803	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
6422; 6423;	GO:0030307	positive regulation of cell growth	2	79	2.53164556962025	0.0588703723550082	0.103130579308044	1	1	0.907423808073593	0.907423808073593	0.767773098121284
5167; 6422; 6423;	GO:0030308	negative regulation of cell growth	3	118	2.54237288135593	0.0210793999091394	0.0671828519880796	1	1	0.843175996365577	0.907423808073593	0.500154142036207
2737;	GO:0030318	melanocyte differentiation	1	17	5.88235294117647	0.083777116024585	0.123923006754394	1	1	0.907423808073593	0.907423808073593	0.92256585255994
3776;	GO:0030322	stabilization of membrane potential	1	16	6.25	0.0793107862791833	0.120092042315483	1	1	0.907423808073593	0.907423808073593	0.894045587709397
6678; 2737; 441376;	GO:0030324	lung development	3	77	3.8961038961039	0.00693092256039951	0.0507325338260943	1	1	0.639578574161436	0.907423808073593	0.377686956987405
2260; 5396;	GO:0030326	embryonic limb morphogenesis	2	38	5.26315789473684	0.0160958679392817	0.0623065855714132	1	1	0.799020555427036	0.907423808073593	0.463851949232596
1277; 4318; 4920; 10457; 131578;	GO:0030335	positive regulation of cell migration	5	190	2.63157894736842	0.00261218935919283	0.0248879842214216	1	1	0.459541310694412	0.907423808073593	0.185282821835018
127435; 23213; 6422; 6423;	GO:0030336	negative regulation of cell migration	4	101	3.96039603960396	0.00170802070239728	0.0199963399305048	1	1	0.404200283317674	0.907423808073593	0.148866145837043
715; 716;	GO:0030449	regulation of complement activation	2	109	1.8348623853211	0.101195498731402	0.13950112622533	1	1	0.907423808073593	0.907423808073593	1
4256; 5167; 7291;	GO:0030500	regulation of bone mineralization	3	17	17.6470588235294	0.000118638539092331	0.00406760705459419	0.110689756973144	0.113892997528637	0.0971649635166187	0.110689756973144	0.0302819909594185
7043;	GO:0030501	positive regulation of bone mineralization	1	34	2.94117647058824	0.156504512363655	0.190907664382603	1	1	0.907423808073593	0.907423808073593	1
5167;	GO:0030505	inorganic diphosphate transport	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
7043; 4920;	GO:0030509	BMP signaling pathway	2	91	2.1978021978022	0.0749176435942357	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
6424;	GO:0030510	regulation of BMP signaling pathway	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
7043;	GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway	1	64	1.5625	0.271172341972617	0.295153569494005	1	1	0.907423808073593	0.907423808073593	1
23213;	GO:0030513	positive regulation of BMP signaling pathway	1	32	3.125	0.148254208227766	0.18176761162025	1	1	0.907423808073593	0.907423808073593	1
6422; 6423;	GO:0030514	negative regulation of BMP signaling pathway	2	45	4.44444444444444	0.0218246625398212	0.0671828519880796	1	1	0.846506290332147	0.907423808073593	0.500154142036207
348;	GO:0030516	regulation of axon extension	1	13	7.69230769230769	0.065782064732448	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
2099;	GO:0030518	intracellular steroid hormone receptor signaling pathway	1	16	6.25	0.0793107862791833	0.120092042315483	1	1	0.907423808073593	0.907423808073593	0.894045587709397
2099;	GO:0030520	intracellular estrogen receptor signaling pathway	1	21	4.76190476190476	0.101428943859667	0.13950112622533	1	1	0.907423808073593	0.907423808073593	1
4920;	GO:0030538	embryonic genitalia morphogenesis	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
4920;	GO:0030539	male genitalia development	1	19	5.26315789473684	0.0926455249139971	0.130601621024137	1	1	0.907423808073593	0.907423808073593	0.972285929800287
1277; 1281; 1290; 1278; 4313; 1301; 1291; 1292; 1293; 4318; 1289; 4320; 1513; 1303;	GO:0030574	collagen catabolic process	14	65	21.5384615384615	0	0	0	0	0	0	0
6363;	GO:0030593	neutrophil chemotaxis	1	63	1.58730158730159	0.267611352780174	0.292938310911023	1	1	0.907423808073593	0.907423808073593	1
5167;	GO:0030643	cellular phosphate ion homeostasis	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
5167;	GO:0030730	sequestering of triglyceride	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
348;	GO:0030828	positive regulation of cGMP biosynthetic process	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
2737;	GO:0030850	prostate gland development	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
6876;	GO:0030855	epithelial cell differentiation	1	69	1.44927536231884	0.288721789147669	0.312836250092282	1	1	0.907423808073593	0.907423808073593	1
7043;	GO:0030879	mammary gland development	1	22	4.54545454545455	0.105789034383918	0.144257774159888	1	1	0.907423808073593	0.907423808073593	1
2260;	GO:0030901	midbrain development	1	32	3.125	0.148254208227766	0.18176761162025	1	1	0.907423808073593	0.907423808073593	1
348;	GO:0031102	neuron projection regeneration	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
146760;	GO:0031103	axon regeneration	1	14	7.14285714285714	0.0703133638315967	0.112689197459654	1	1	0.907423808073593	0.907423808073593	0.838933852974602
23194;	GO:0031146	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	1	73	1.36986301369863	0.302459586409567	0.323702567394854	1	1	0.907423808073593	0.907423808073593	1
5167;	GO:0031214	biomineral tissue development	1	25	4	0.118744029737539	0.156370738749023	1	1	0.907423808073593	0.907423808073593	1
3956; 6363;	GO:0031295	T cell costimulation	2	73	2.73972602739726	0.051362682164084	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
26471;	GO:0031401	positive regulation of protein modification process	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
715;	GO:0031638	zymogen activation	1	14	7.14285714285714	0.0703133638315967	0.112689197459654	1	1	0.907423808073593	0.907423808073593	0.838933852974602
6423;	GO:0031668	cellular response to extracellular stimulus	1	18	5.55555555555556	0.0882219949067566	0.127358067835318	1	1	0.907423808073593	0.907423808073593	0.948138747680206
2625;	GO:0031929	TOR signaling	1	16	6.25	0.0793107862791833	0.120092042315483	1	1	0.907423808073593	0.907423808073593	0.894045587709397
5167;	GO:0031953	negative regulation of protein autophosphorylation	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
10457;	GO:0031954	positive regulation of protein autophosphorylation	1	23	4.34782608695652	0.110128179209321	0.148696275725666	1	1	0.907423808073593	0.907423808073593	1
1277;	GO:0031960	response to corticosteroid	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
7291;	GO:0032000	positive regulation of fatty acid beta-oxidation	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
5740;	GO:0032088	negative regulation of NF-kappaB transcription factor activity	1	87	1.14942528735632	0.348505276646809	0.365245704782682	1	1	0.907423808073593	0.907423808073593	1
115908;	GO:0032092	positive regulation of protein binding	1	63	1.58730158730159	0.267611352780174	0.292938310911023	1	1	0.907423808073593	0.907423808073593	1
348;	GO:0032269	negative regulation of cellular protein metabolic process	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
2737;	GO:0032332	positive regulation of chondrocyte differentiation	1	19	5.26315789473684	0.0926455249139971	0.130601621024137	1	1	0.907423808073593	0.907423808073593	0.972285929800287
1277; 2099; 10631;	GO:0032355	response to estradiol	3	89	3.37078651685393	0.0101613905511859	0.0524458867157983	1	1	0.702848712680632	0.907423808073593	0.390442303317555
348;	GO:0032374	regulation of cholesterol transport	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
348;	GO:0032462	regulation of protein homooligomerization	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
7077;	GO:0032487	regulation of Rap protein signal transduction	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
348;	GO:0032489	regulation of Cdc42 protein signal transduction	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
1634; 6678; 4016;	GO:0032496	response to lipopolysaccharide	3	167	1.79640718562874	0.0497841204250661	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
7043;	GO:0032570	response to progesterone	1	41	2.4390243902439	0.184762389447543	0.216307187645904	1	1	0.907423808073593	0.907423808073593	1
2625;	GO:0032689	negative regulation of interferon-gamma production	1	25	4	0.118744029737539	0.156370738749023	1	1	0.907423808073593	0.907423808073593	1
2625;	GO:0032703	negative regulation of interleukin-2 production	1	12	8.33333333333333	0.0612289019715984	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
10457; 7291;	GO:0032720	negative regulation of tumor necrosis factor production	2	39	5.12820512820513	0.0168684529554246	0.0638195406695263	1	1	0.809685741860381	0.907423808073593	0.47511540019729
6363;	GO:0032735	positive regulation of interleukin-12 production	1	25	4	0.118744029737539	0.156370738749023	1	1	0.907423808073593	0.907423808073593	1
2625;	GO:0032753	positive regulation of interleukin-4 production	1	20	5	0.0970478075547262	0.13502303659788	1	1	0.907423808073593	0.907423808073593	1
7291; 6363;	GO:0032760	positive regulation of tumor necrosis factor production	2	46	4.34782608695652	0.0227026292174961	0.0671828519880796	1	1	0.849794970558768	0.907423808073593	0.500154142036207
348;	GO:0032805	positive regulation of low-density lipoprotein particle receptor catabolic process	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
23213;	GO:0032836	glomerular basement membrane development	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
5167;	GO:0032869	cellular response to insulin stimulus	1	85	1.17647058823529	0.342116389181948	0.359728076248269	1	1	0.907423808073593	0.907423808073593	1
4060;	GO:0032914	positive regulation of transforming growth factor beta1 production	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
1277; 1289;	GO:0032964	collagen biosynthetic process	2	8	25	0.0010205192546171	0.0137394683106962	0.909282655863838	0.979698484432419	0.325181690439646	0.907423808073593	0.102285803320603
7431; 7043;	GO:0032967	positive regulation of collagen biosynthetic process	2	25	8	0.00754453822179602	0.0507325338260943	1	1	0.651895927539605	0.907423808073593	0.377686956987405
2737;	GO:0033077	T cell differentiation in thymus	1	26	3.84615384615385	0.123020933257398	0.160462086857476	1	1	0.907423808073593	0.907423808073593	1
7291;	GO:0033128	negative regulation of histone phosphorylation	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
6423;	GO:0033138	positive regulation of peptidyl-serine phosphorylation	1	83	1.20481927710843	0.335665481652992	0.353719936758367	1	1	0.907423808073593	0.907423808073593	1
2099;	GO:0033146	regulation of intracellular estrogen receptor signaling pathway	1	15	6.66666666666667	0.0748229031998671	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
348;	GO:0033344	cholesterol efflux	1	24	4.16666666666667	0.114446477946567	0.152807536618504	1	1	0.907423808073593	0.907423808073593	1
6678;	GO:0033591	response to L-ascorbic acid	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
2625;	GO:0033600	negative regulation of mammary gland epithelial cell proliferation	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
2335;	GO:0033622	integrin activation	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
22801;	GO:0033627	cell adhesion mediated by integrin	1	16	6.25	0.0793107862791833	0.120092042315483	1	1	0.907423808073593	0.907423808073593	0.894045587709397
6423;	GO:0033630	positive regulation of cell adhesion mediated by integrin	1	13	7.69230769230769	0.065782064732448	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
4920; 2260;	GO:0033674	positive regulation of kinase activity	2	67	2.98507462686567	0.044234861726416	0.0895895933699564	1	1	0.907423808073593	0.907423808073593	0.666964930504494
6422;	GO:0033689	negative regulation of osteoblast proliferation	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
115908;	GO:0033690	positive regulation of osteoblast proliferation	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
348;	GO:0033700	phospholipid efflux	1	12	8.33333333333333	0.0612289019715984	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
1281; 6678; 7077;	GO:0034097	response to cytokine	3	48	6.25	0.00194378105570636	0.0216852801389006	1	1	0.420063638965367	0.907423808073593	0.161439747818551
7060; 10457;	GO:0034103	regulation of tissue remodeling	2	4	50	0.000344508113106268	0.00674954670575545	0.315569431605341	0.330727788582017	0.188735121386135	0.314191399152916	0.0502481457969275
3956;	GO:0034120	positive regulation of erythrocyte aggregation	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
2099;	GO:0034121	regulation of toll-like receptor signaling pathway	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
81035;	GO:0034138	toll-like receptor 3 signaling pathway	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
5740;	GO:0034356	NAD biosynthesis via nicotinamide riboside salvage pathway	1	15	6.66666666666667	0.0748229031998671	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
348;	GO:0034371	chylomicron remodeling	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
348;	GO:0034372	very-low-density lipoprotein particle remodeling	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
348;	GO:0034374	low-density lipoprotein particle remodeling	1	13	7.69230769230769	0.065782064732448	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
348;	GO:0034375	high-density lipoprotein particle remodeling	1	17	5.88235294117647	0.083777116024585	0.123923006754394	1	1	0.907423808073593	0.907423808073593	0.92256585255994
348;	GO:0034378	chylomicron assembly	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
348;	GO:0034380	high-density lipoprotein particle assembly	1	13	7.69230769230769	0.065782064732448	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
348;	GO:0034382	chylomicron remnant clearance	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
348;	GO:0034384	high-density lipoprotein particle clearance	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
2335;	GO:0034446	substrate adhesion-dependent cell spreading	1	41	2.4390243902439	0.184762389447543	0.216307187645904	1	1	0.907423808073593	0.907423808073593	1
348;	GO:0034447	very-low-density lipoprotein particle clearance	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
1277;	GO:0034504	protein localization to nucleus	1	31	3.2258064516129	0.144099148021041	0.178037557400514	1	1	0.907423808073593	0.907423808073593	1
1277;	GO:0034505	tooth mineralization	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
4318;	GO:0034614	cellular response to reactive oxygen species	1	35	2.85714285714286	0.160599945882917	0.194666601070202	1	1	0.907423808073593	0.907423808073593	1
7043;	GO:0034616	response to laminar fluid shear stress	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
54898;	GO:0034625	fatty acid elongation, monounsaturated fatty acid	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
54898;	GO:0034626	fatty acid elongation, polyunsaturated fatty acid	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
6363;	GO:0034695	response to prostaglandin E	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
7060; 8406;	GO:0034976	response to endoplasmic reticulum stress	2	73	2.73972602739726	0.051362682164084	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
6422;	GO:0035019	somatic stem cell population maintenance	1	64	1.5625	0.271172341972617	0.295153569494005	1	1	0.907423808073593	0.907423808073593	1
1281;	GO:0035025	positive regulation of Rho protein signal transduction	1	26	3.84615384615385	0.123020933257398	0.160462086857476	1	1	0.907423808073593	0.907423808073593	1
7291;	GO:0035067	negative regulation of histone acetylation	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
2737;	GO:0035108	limb morphogenesis	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
1382; 7291;	GO:0035115	embryonic forelimb morphogenesis	2	31	6.45161290322581	0.0111372214065372	0.0556861070326858	1	1	0.723919391424916	0.907423808073593	0.414564673306979
7291;	GO:0035116	embryonic hindlimb morphogenesis	1	28	3.57142857142857	0.131513187863543	0.167443846616713	1	1	0.907423808073593	0.907423808073593	1
2625;	GO:0035162	embryonic hemopoiesis	1	16	6.25	0.0793107862791833	0.120092042315483	1	1	0.907423808073593	0.907423808073593	0.894045587709397
1289;	GO:0035313	wound healing, spreading of epidermal cells	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
54898;	GO:0035338	long-chain fatty-acyl-CoA biosynthetic process	1	18	5.55555555555556	0.0882219949067566	0.127358067835318	1	1	0.907423808073593	0.907423808073593	0.948138747680206
7291;	GO:0035359	negative regulation of peroxisome proliferator activated receptor signaling pathway	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
5740;	GO:0035360	positive regulation of peroxisome proliferator activated receptor signaling pathway	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
2625;	GO:0035457	cellular response to interferon-alpha	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
6424; 6423; 6422;	GO:0035567	non-canonical Wnt signaling pathway	3	22	13.6363636363636	0.000235183081189971	0.0053756132843422	0.216368434694774	0.225775757942372	0.153574552017051	0.216133251613584	0.0400196652953295
2260;	GO:0035607	fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
348;	GO:0035641	locomotory exploration behavior	1	13	7.69230769230769	0.065782064732448	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
5157;	GO:0035791	platelet-derived growth factor receptor-beta signaling pathway	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
2625;	GO:0035799	ureter maturation	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
23213;	GO:0035860	glial cell-derived neurotrophic factor receptor signaling pathway	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
2625;	GO:0035898	parathyroid hormone secretion	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
3956;	GO:0035900	response to isolation stress	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
4016;	GO:0035904	aorta development	1	18	5.55555555555556	0.0882219949067566	0.127358067835318	1	1	0.907423808073593	0.907423808073593	0.948138747680206
26471;	GO:0035914	skeletal muscle cell differentiation	1	47	2.12765957446809	0.208236064581996	0.238837063319852	1	1	0.907423808073593	0.907423808073593	1
2619;	GO:0035924	cellular response to vascular endothelial growth factor stimulus	1	24	4.16666666666667	0.114446477946567	0.152807536618504	1	1	0.907423808073593	0.907423808073593	1
2335; 4313; 1301; 1291; 4318; 1303;	GO:0035987	endodermal cell differentiation	6	28	21.4285714285714	1.34259510176093e-08	1.841273282415e-06	1.28083572707993e-05	1.2888912976905e-05	1.28083572707993e-05	1.28083572707993e-05	1.37076714007894e-05
1301; 1289;	GO:0035989	tendon development	2	3	66.6666666666667	0.000230400979116863	0.0053756132843422	0.212429702745747	0.221184939952188	0.151691151877005	0.21219930176663	0.0400196652953295
2260;	GO:0036092	phosphatidylinositol-3-phosphate biosynthetic process	1	50	2	0.219720710746885	0.249623529369243	1	1	0.907423808073593	0.907423808073593	1
54898;	GO:0036109	alpha-linolenic acid metabolic process	1	13	7.69230769230769	0.065782064732448	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
6423;	GO:0036342	post-anal tail morphogenesis	1	16	6.25	0.0793107862791833	0.120092042315483	1	1	0.907423808073593	0.907423808073593	0.894045587709397
2134;	GO:0036498	IRE1-mediated unfolded protein response	1	58	1.72413793103448	0.249546393809154	0.277595061479476	1	1	0.907423808073593	0.907423808073593	1
1277;	GO:0038063	collagen-activated tyrosine kinase receptor signaling pathway	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
22801;	GO:0038065	collagen-activated signaling pathway	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
23213;	GO:0040036	regulation of fibroblast growth factor receptor signaling pathway	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
23213;	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	1	14	7.14285714285714	0.0703133638315967	0.112689197459654	1	1	0.907423808073593	0.907423808073593	0.838933852974602
2625;	GO:0042035	regulation of cytokine biosynthetic process	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
1281; 2335; 1634; 6678; 2737; 7043;	GO:0042060	wound healing	6	78	7.69230769230769	3.33796761264882e-06	0.000267037409011905	0.00316773126440373	0.00320444890814287	0.00315771736156578	0.00316773126440373	0.00198800530557439
6363;	GO:0042102	positive regulation of T cell proliferation	1	60	1.66666666666667	0.256824711810009	0.283392785445527	1	1	0.907423808073593	0.907423808073593	1
7043;	GO:0042127	regulation of cell proliferation	1	197	0.50761421319797	0.619659479186554	0.628165892311607	1	1	0.907423808073593	0.907423808073593	1
10457;	GO:0042130	negative regulation of T cell proliferation	1	39	2.56410256410256	0.176785747420046	0.209265496329524	1	1	0.907423808073593	0.907423808073593	1
348;	GO:0042157	lipoprotein metabolic process	1	19	5.26315789473684	0.0926455249139971	0.130601621024137	1	1	0.907423808073593	0.907423808073593	0.972285929800287
348;	GO:0042158	lipoprotein biosynthetic process	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
348;	GO:0042159	lipoprotein catabolic process	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
347;	GO:0042246	tissue regeneration	1	21	4.76190476190476	0.101428943859667	0.13950112622533	1	1	0.907423808073593	0.907423808073593	1
2737;	GO:0042307	positive regulation of protein import into nucleus	1	29	3.44827586206897	0.135728733985959	0.170549194537331	1	1	0.907423808073593	0.907423808073593	1
347;	GO:0042308	negative regulation of protein import into nucleus	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
348;	GO:0042311	vasodilation	1	20	5	0.0970478075547262	0.13502303659788	1	1	0.907423808073593	0.907423808073593	1
4060;	GO:0042340	keratan sulfate catabolic process	1	12	8.33333333333333	0.0612289019715984	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
2625;	GO:0042421	norepinephrine biosynthetic process	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
2260; 1301; 2625; 5396; 4920;	GO:0042472	inner ear morphogenesis	5	53	9.43396226415094	9.04118965305845e-06	0.000545246039045377	0.00855296541179329	0.00867954206693611	0.00851680065318106	0.00855296541179329	0.00405917666171373
2260; 7291;	GO:0042473	outer ear morphogenesis	2	9	22.2222222222222	0.00124336246840029	0.0158857948580037	1	1	0.354250414713956	0.907423808073593	0.118264495517067
2260; 5396;	GO:0042474	middle ear morphogenesis	2	20	10	0.00504394515129392	0.0410354859766285	1	1	0.569965802096213	0.907423808073593	0.305495638757953
2737;	GO:0042475	odontogenesis of dentin-containing tooth	1	56	1.78571428571429	0.242197515010149	0.271306434550458	1	1	0.907423808073593	0.907423808073593	1
1278; 7043; 7291;	GO:0042476	odontogenesis	3	31	9.67741935483871	0.000592833255952829	0.00981241251232269	0.535921263381358	0.569119925714716	0.251898305432457	0.535328430125405	0.0730501700385819
347; 3956; 7077; 6422; 6423;	GO:0042493	response to drug	5	190	2.63157894736842	0.00261218935919283	0.0248879842214216	1	1	0.459541310694412	0.907423808073593	0.185282821835018
1277;	GO:0042542	response to hydrogen peroxide	1	45	2.22222222222222	0.20048682463311	0.231053243274653	1	1	0.907423808073593	0.907423808073593	1
1382;	GO:0042573	retinoic acid metabolic process	1	15	6.66666666666667	0.0748229031998671	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
348;	GO:0042632	cholesterol homeostasis	1	74	1.35135135135135	0.305852787818102	0.325880883801751	1	1	0.907423808073593	0.907423808073593	1
6423;	GO:0042662	negative regulation of mesodermal cell fate specification	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
5176;	GO:0042698	ovulation cycle	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
7043;	GO:0042704	uterine wall breakdown	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
2737; 4920; 7291; 6423;	GO:0042733	embryonic digit morphogenesis	4	57	7.01754385964912	0.000219378125008718	0.0053756132843422	0.202924765633064	0.210603000008369	0.147422100005858	0.202705387508055	0.0400196652953295
54898;	GO:0042761	very long-chain fatty acid biosynthetic process	1	13	7.69230769230769	0.065782064732448	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
26471;	GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	1	29	3.44827586206897	0.135728733985959	0.170549194537331	1	1	0.907423808073593	0.907423808073593	1
2099; 3956; 7043; 2619; 5740;	GO:0042981	regulation of apoptotic process	5	273	1.83150183150183	0.0114233331866094	0.0565278343254897	1	1	0.730232428759098	0.907423808073593	0.420831054972876
348;	GO:0042982	amyloid precursor protein metabolic process	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
2260;	GO:0043009	chordate embryonic development	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
26471; 7043; 6424; 6422; 6423;	GO:0043065	positive regulation of apoptotic process	5	315	1.58730158730159	0.0198154876861985	0.0653706810266341	1	1	0.835082453755465	0.907423808073593	0.486663127802314
2737; 4318; 1311; 7291; 6422; 4920; 2260;	GO:0043066	negative regulation of apoptotic process	7	522	1.34099616858238	0.0144825735671595	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
3956; 6363;	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	2	167	1.19760479041916	0.197670463195649	0.228355769756706	1	1	0.907423808073593	0.907423808073593	1
2099;	GO:0043124	negative regulation of I-kappaB kinase/NF-kappaB signaling	1	42	2.38095238095238	0.188721967914471	0.219337880384858	1	1	0.907423808073593	0.907423808073593	1
6423;	GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	1	72	1.38888888888889	0.299049964679206	0.321127478850154	1	1	0.907423808073593	0.907423808073593	1
4240;	GO:0043277	apoptotic cell clearance	1	19	5.26315789473684	0.0926455249139971	0.130601621024137	1	1	0.907423808073593	0.907423808073593	0.972285929800287
4318; 7077;	GO:0043312	neutrophil degranulation	2	478	0.418410041841004	0.679501929820652	0.685932547453024	1	1	0.907423808073593	0.907423808073593	1
2625;	GO:0043370	regulation of CD4-positive, alpha-beta T cell differentiation	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
4318;	GO:0043388	positive regulation of DNA binding	1	27	3.7037037037037	0.127277286716657	0.164449791720041	1	1	0.907423808073593	0.907423808073593	1
148252; 2260;	GO:0043406	positive regulation of MAP kinase activity	2	58	3.44827586206897	0.0343181089303105	0.0799645256628594	1	1	0.905702534411319	0.907423808073593	0.595309480659381
348;	GO:0043407	negative regulation of MAP kinase activity	1	38	2.63157894736842	0.172768500433013	0.205778859076542	1	1	0.907423808073593	0.907423808073593	1
7043;	GO:0043408	regulation of MAPK cascade	1	54	1.85185185185185	0.234777398326665	0.264537913607509	1	1	0.907423808073593	0.907423808073593	1
2260; 7077; 4920;	GO:0043410	positive regulation of MAPK cascade	3	141	2.12765957446809	0.0329615869543186	0.078119488901253	1	1	0.898410243474029	0.907423808073593	0.581573791399117
2099; 7291; 6424;	GO:0043433	negative regulation of DNA binding transcription factor activity	3	61	4.91803278688525	0.00371617366270283	0.0321398803260785	1	1	0.51163540614106	0.907423808073593	0.23927079297688
1277; 6678;	GO:0043434	response to peptide hormone	2	43	4.65116279069767	0.0201125974456863	0.065451164569013	1	1	0.837706848644703	0.907423808073593	0.487262301190989
6678;	GO:0043473	pigmentation	1	25	4	0.118744029737539	0.156370738749023	1	1	0.907423808073593	0.907423808073593	1
7431;	GO:0043488	regulation of mRNA stability	1	109	0.917431192660551	0.414854631181229	0.43055183344214	1	1	0.907423808073593	0.907423808073593	1
4920;	GO:0043507	positive regulation of JUN kinase activity	1	34	2.94117647058824	0.156504512363655	0.190907664382603	1	1	0.907423808073593	0.907423808073593	1
6422; 6423;	GO:0043508	negative regulation of JUN kinase activity	2	14	14.2857142857143	0.00267027330709002	0.0248879842214216	1	1	0.461957282126574	0.907423808073593	0.185282821835018
7291;	GO:0043518	negative regulation of DNA damage response, signal transduction by p53 class mediator	1	14	7.14285714285714	0.0703133638315967	0.112689197459654	1	1	0.907423808073593	0.907423808073593	0.838933852974602
2625;	GO:0043523	regulation of neuron apoptotic process	1	18	5.55555555555556	0.0882219949067566	0.127358067835318	1	1	0.907423808073593	0.907423808073593	0.948138747680206
348; 7043;	GO:0043524	negative regulation of neuron apoptotic process	2	130	1.53846153846154	0.134483016001943	0.170549194537331	1	1	0.907423808073593	0.907423808073593	1
2260;	GO:0043536	positive regulation of blood vessel endothelial cell migration	1	37	2.7027027027027	0.168731846455733	0.202225433954437	1	1	0.907423808073593	0.907423808073593	1
348;	GO:0043537	negative regulation of blood vessel endothelial cell migration	1	18	5.55555555555556	0.0882219949067566	0.127358067835318	1	1	0.907423808073593	0.907423808073593	0.948138747680206
2191;	GO:0043542	endothelial cell migration	1	29	3.44827586206897	0.135728733985959	0.170549194537331	1	1	0.907423808073593	0.907423808073593	1
6422; 6363;	GO:0043547	positive regulation of GTPase activity	2	330	0.606060606060606	0.480103915957605	0.492940919058075	1	1	0.907423808073593	0.907423808073593	1
6363;	GO:0043552	positive regulation of phosphatidylinositol 3-kinase activity	1	28	3.57142857142857	0.131513187863543	0.167443846616713	1	1	0.907423808073593	0.907423808073593	1
8483;	GO:0043569	negative regulation of insulin-like growth factor receptor signaling pathway	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
2625;	GO:0043583	ear development	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
2737;	GO:0043585	nose morphogenesis	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
2737;	GO:0043586	tongue development	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
1281; 1290; 1289;	GO:0043588	skin development	3	32	9.375	0.000646138806115859	0.0100047299011488	0.580878786698157	0.620293253871225	0.262332355283039	0.580878786698157	0.0744819094744729
1277; 1278;	GO:0043589	skin morphogenesis	2	9	22.2222222222222	0.00124336246840029	0.0158857948580037	1	1	0.354250414713956	0.907423808073593	0.118264495517067
2099; 2737; 7043; 2625;	GO:0043627	response to estrogen	4	63	6.34920634920635	0.000315132854190936	0.00674954670575545	0.288976827293088	0.302527540023299	0.180564237332382	0.288976827293088	0.0502481457969275
54898;	GO:0043651	linoleic acid metabolic process	1	17	5.88235294117647	0.083777116024585	0.123923006754394	1	1	0.907423808073593	0.907423808073593	0.92256585255994
348; 2335; 3956; 4240; 340075; 83987; 23194;	GO:0043687	post-translational protein modification	7	354	1.9774011299435	0.0018850319642485	0.0212897727726889	1	1	0.416592064098918	0.907423808073593	0.158495326116244
348;	GO:0043691	reverse cholesterol transport	1	17	5.88235294117647	0.083777116024585	0.123923006754394	1	1	0.907423808073593	0.907423808073593	0.92256585255994
7043; 115908;	GO:0043932	ossification involved in bone remodeling	2	4	50	0.000344508113106268	0.00674954670575545	0.315569431605341	0.330727788582017	0.188735121386135	0.314191399152916	0.0502481457969275
348; 2335; 4313; 3956; 4240; 29995;	GO:0044267	cellular protein metabolic process	6	192	3.125	0.00040857555186613	0.00754293326522087	0.371395176646313	0.392232529791485	0.206513813244417	0.371395176646313	0.0561546466704375
1277; 10631; 6422;	GO:0044344	cellular response to fibroblast growth factor stimulus	3	28	10.7142857142857	0.000450035680721328	0.00785516824531772	0.408632398094966	0.432034253492475	0.218121745549945	0.407732326733523	0.0584791329636324
6422;	GO:0044345	stromal-epithelial cell signaling involved in prostate gland development	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
1277;	GO:0044691	tooth eruption	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
11178;	GO:0044772	mitotic cell cycle phase transition	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
348;	GO:0044794	positive regulation by host of viral process	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
5740;	GO:0045019	negative regulation of nitric oxide biosynthetic process	1	12	8.33333333333333	0.0612289019715984	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
2737;	GO:0045060	negative thymic T cell selection	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
2625;	GO:0045061	thymic T cell selection	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
2625;	GO:0045064	T-helper 2 cell differentiation	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
715; 2625; 81035;	GO:0045087	innate immune response	3	513	0.584795321637427	0.45839248453829	0.472671090393941	1	1	0.907423808073593	0.907423808073593	1
4313;	GO:0045089	positive regulation of innate immune response	1	20	5	0.0970478075547262	0.13502303659788	1	1	0.907423808073593	0.907423808073593	1
7431;	GO:0045109	intermediate filament organization	1	17	5.88235294117647	0.083777116024585	0.123923006754394	1	1	0.907423808073593	0.907423808073593	0.92256585255994
1289;	GO:0045112	integrin biosynthetic process	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
2619; 4920; 2625;	GO:0045165	cell fate commitment	3	52	5.76923076923077	0.00241472498219275	0.0238983091021138	1	1	0.447941878221786	0.907423808073593	0.17791501746911
7043;	GO:0045216	cell-cell junction organization	1	19	5.26315789473684	0.0926455249139971	0.130601621024137	1	1	0.907423808073593	0.907423808073593	0.972285929800287
3956;	GO:0045445	myoblast differentiation	1	19	5.26315789473684	0.0926455249139971	0.130601621024137	1	1	0.907423808073593	0.907423808073593	0.972285929800287
1513;	GO:0045453	bone resorption	1	22	4.54545454545455	0.105789034383918	0.144257774159888	1	1	0.907423808073593	0.907423808073593	1
6678; 2625;	GO:0045471	response to ethanol	2	101	1.98019801980198	0.0892214468376329	0.128607490937128	1	1	0.907423808073593	0.907423808073593	0.957440289979083
348;	GO:0045541	negative regulation of cholesterol biosynthetic process	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
6422;	GO:0045578	negative regulation of B cell differentiation	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
2625;	GO:0045582	positive regulation of T cell differentiation	1	17	5.88235294117647	0.083777116024585	0.123923006754394	1	1	0.907423808073593	0.907423808073593	0.92256585255994
2260;	GO:0045595	regulation of cell differentiation	1	32	3.125	0.148254208227766	0.18176761162025	1	1	0.907423808073593	0.907423808073593	1
5167; 2625; 4320;	GO:0045599	negative regulation of fat cell differentiation	3	45	6.66666666666667	0.00163142895508417	0.019335454282479	1	1	0.398068665040537	0.907423808073593	0.143946070483127
6422; 6423;	GO:0045600	positive regulation of fat cell differentiation	2	49	4.08163265306122	0.0254223671508262	0.0709461408860267	1	1	0.864360483128092	0.907423808073593	0.528170584838026
6424;	GO:0045606	positive regulation of epidermal cell differentiation	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
1513;	GO:0045616	regulation of keratinocyte differentiation	1	16	6.25	0.0793107862791833	0.120092042315483	1	1	0.907423808073593	0.907423808073593	0.894045587709397
6363;	GO:0045627	positive regulation of T-helper 1 cell differentiation	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
4920;	GO:0045651	positive regulation of macrophage differentiation	1	13	7.69230769230769	0.065782064732448	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
10398;	GO:0045652	regulation of megakaryocyte differentiation	1	42	2.38095238095238	0.188721967914471	0.219337880384858	1	1	0.907423808073593	0.907423808073593	1
2737;	GO:0045665	negative regulation of neuron differentiation	1	59	1.69491525423729	0.253194330840938	0.280030596321775	1	1	0.907423808073593	0.907423808073593	1
2260; 7077;	GO:0045666	positive regulation of neuron differentiation	2	79	2.53164556962025	0.0588703723550082	0.103130579308044	1	1	0.907423808073593	0.907423808073593	0.767773098121284
7291; 6422;	GO:0045668	negative regulation of osteoblast differentiation	2	43	4.65116279069767	0.0201125974456863	0.065451164569013	1	1	0.837706848644703	0.907423808073593	0.487262301190989
2737; 115908; 6423;	GO:0045669	positive regulation of osteoblast differentiation	3	57	5.26315789473684	0.00309513202951495	0.0277694088629378	1	1	0.484206446314593	0.907423808073593	0.206734076534287
6422;	GO:0045671	negative regulation of osteoclast differentiation	1	23	4.34782608695652	0.110128179209321	0.148696275725666	1	1	0.907423808073593	0.907423808073593	1
5167;	GO:0045719	negative regulation of glycogen biosynthetic process	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
7431;	GO:0045727	positive regulation of translation	1	62	1.61290322580645	0.264033139729474	0.290345720664713	1	1	0.907423808073593	0.907423808073593	1
4318;	GO:0045742	positive regulation of epidermal growth factor receptor signaling pathway	1	25	4	0.118744029737539	0.156370738749023	1	1	0.907423808073593	0.907423808073593	1
7077;	GO:0045762	positive regulation of adenylate cyclase activity	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
10457; 6422;	GO:0045765	regulation of angiogenesis	2	31	6.45161290322581	0.0111372214065372	0.0556861070326858	1	1	0.723919391424916	0.907423808073593	0.414564673306979
8038; 7291; 5740; 6423;	GO:0045766	positive regulation of angiogenesis	4	129	3.10077519379845	0.00401568738891755	0.0337565951430407	1	1	0.524760818858988	0.907423808073593	0.251306700775769
2335;	GO:0045773	positive regulation of axon extension	1	31	3.2258064516129	0.144099148021041	0.178037557400514	1	1	0.907423808073593	0.907423808073593	1
26471; 2625;	GO:0045786	negative regulation of cell cycle	2	38	5.26315789473684	0.0160958679392817	0.0623065855714132	1	1	0.799020555427036	0.907423808073593	0.463851949232596
348; 6363;	GO:0045807	positive regulation of endocytosis	2	23	8.69565217391304	0.00648900951463705	0.0507325338260943	1	1	0.630761665226208	0.907423808073593	0.377686956987405
6363;	GO:0045860	positive regulation of protein kinase activity	1	54	1.85185185185185	0.234777398326665	0.264537913607509	1	1	0.907423808073593	0.907423808073593	1
2737;	GO:0045879	negative regulation of smoothened signaling pathway	1	22	4.54545454545455	0.105789034383918	0.144257774159888	1	1	0.907423808073593	0.907423808073593	1
5396; 6422;	GO:0045880	positive regulation of smoothened signaling pathway	2	30	6.66666666666667	0.0104951125901793	0.0533085083945616	1	1	0.711215959260163	0.907423808073593	0.396864236785343
2737; 2625; 7291; 6422; 6423;	GO:0045892	negative regulation of transcription, DNA-templated	5	498	1.00401606425703	0.0977202944710702	0.135761914171096	1	1	0.907423808073593	0.907423808073593	1
1277; 2099; 2737; 7043; 2625; 4920; 6422;	GO:0045893	positive regulation of transcription, DNA-templated	7	546	1.28205128205128	0.0180338407049528	0.0638195406695263	1	1	0.826523709605657	0.907423808073593	0.47511540019729
2099;	GO:0045899	positive regulation of RNA polymerase II transcriptional preinitiation complex assembly	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
7077; 2619;	GO:0045930	negative regulation of mitotic cell cycle	2	27	7.40740740740741	0.00867205460520437	0.0507325338260943	1	1	0.675150241244942	0.907423808073593	0.377686956987405
4010; 2099; 1634; 2737; 7043; 2625; 4060; 5396; 7291; 6423; 56917;	GO:0045944	positive regulation of transcription by RNA polymerase II	11	1060	1.0377358490566	0.0145950894765582	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
5167;	GO:0046034	ATP metabolic process	1	32	3.125	0.148254208227766	0.18176761162025	1	1	0.907423808073593	0.907423808073593	1
5167;	GO:0046325	negative regulation of glucose import	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
6363;	GO:0046330	positive regulation of JNK cascade	1	67	1.49253731343284	0.281752785209126	0.305630139887866	1	1	0.907423808073593	0.907423808073593	1
1634; 633; 127435; 146760; 131578;	GO:0046426	negative regulation of JAK-STAT cascade	5	44	11.3636363636364	3.8946051641453e-06	0.000275539153398492	0.00369208569560975	0.00373882095757949	0.00368429648528146	0.00369208569560975	0.00205129798434067
7077;	GO:0046580	negative regulation of Ras protein signal transduction	1	27	3.7037037037037	0.127277286716657	0.164449791720041	1	1	0.907423808073593	0.907423808073593	1
3956;	GO:0046598	positive regulation of viral entry into host cell	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
5167;	GO:0046627	negative regulation of insulin receptor signaling pathway	1	31	3.2258064516129	0.144099148021041	0.178037557400514	1	1	0.907423808073593	0.907423808073593	1
2737;	GO:0046638	positive regulation of alpha-beta T cell differentiation	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
2737;	GO:0046639	negative regulation of alpha-beta T cell differentiation	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
6422;	GO:0046676	negative regulation of insulin secretion	1	27	3.7037037037037	0.127277286716657	0.164449791720041	1	1	0.907423808073593	0.907423808073593	1
5176;	GO:0046685	response to arsenic-containing substance	1	13	7.69230769230769	0.065782064732448	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
6678;	GO:0046686	response to cadmium ion	1	24	4.16666666666667	0.114446477946567	0.152807536618504	1	1	0.907423808073593	0.907423808073593	1
5740;	GO:0046697	decidualization	1	20	5	0.0970478075547262	0.13502303659788	1	1	0.907423808073593	0.907423808073593	1
2260;	GO:0046777	protein autophosphorylation	1	168	0.595238095238095	0.561553381156992	0.571071235074907	1	1	0.907423808073593	0.907423808073593	1
131578;	GO:0046813	receptor-mediated virion attachment to host cell	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
6422;	GO:0046851	negative regulation of bone remodeling	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
2099; 2260;	GO:0046854	phosphatidylinositol phosphorylation	2	103	1.94174757281553	0.0921732018205316	0.130601621024137	1	1	0.907423808073593	0.907423808073593	0.972285929800287
348;	GO:0046889	positive regulation of lipid biosynthetic process	1	15	6.66666666666667	0.0748229031998671	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
348;	GO:0046907	intracellular transport	1	25	4	0.118744029737539	0.156370738749023	1	1	0.907423808073593	0.907423808073593	1
23213;	GO:0048010	vascular endothelial growth factor receptor signaling pathway	1	70	1.42857142857143	0.2921811452629	0.315871508392324	1	1	0.907423808073593	0.907423808073593	1
4313; 4318;	GO:0048013	ephrin receptor signaling pathway	2	86	2.32558139534884	0.0680731906798705	0.111329238590589	1	1	0.907423808073593	0.907423808073593	0.828809408399332
2260;	GO:0048015	phosphatidylinositol-mediated signaling	1	43	2.32558139534884	0.192662506247941	0.222838561443402	1	1	0.907423808073593	0.907423808073593	1
4237;	GO:0048048	embryonic eye morphogenesis	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
4237;	GO:0048050	post-embryonic eye morphogenesis	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
2335; 2099;	GO:0048146	positive regulation of fibroblast proliferation	2	50	4	0.0263570384828616	0.0725955692646671	1	1	0.869761957648965	0.907423808073593	0.540450034298067
26471; 6422;	GO:0048147	negative regulation of fibroblast proliferation	2	28	7.14285714285714	0.00926235031401856	0.0507325338260943	1	1	0.685413923237374	0.907423808073593	0.377686956987405
348;	GO:0048168	regulation of neuronal synaptic plasticity	1	16	6.25	0.0793107862791833	0.120092042315483	1	1	0.907423808073593	0.907423808073593	0.894045587709397
6363;	GO:0048247	lymphocyte chemotaxis	1	31	3.2258064516129	0.144099148021041	0.178037557400514	1	1	0.907423808073593	0.907423808073593	1
4016;	GO:0048251	elastic fiber assembly	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
6363;	GO:0048260	positive regulation of receptor-mediated endocytosis	1	20	5	0.0970478075547262	0.13502303659788	1	1	0.907423808073593	0.907423808073593	1
7060;	GO:0048266	behavioral response to pain	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
7043;	GO:0048286	lung alveolus development	1	31	3.2258064516129	0.144099148021041	0.178037557400514	1	1	0.907423808073593	0.907423808073593	1
2260;	GO:0048339	paraxial mesoderm development	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
2260;	GO:0048378	regulation of lateral mesodermal cell fate specification	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
1382;	GO:0048385	regulation of retinoic acid receptor signaling pathway	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
7043; 2625;	GO:0048468	cell development	2	50	4	0.0263570384828616	0.0725955692646671	1	1	0.869761957648965	0.907423808073593	0.540450034298067
2260; 2625; 6363;	GO:0048469	cell maturation	3	37	8.10810810810811	0.000958415524427103	0.0133344768615945	0.854906647788976	0.920078903450019	0.317091225277615	0.854906647788976	0.0992707757538454
2625;	GO:0048485	sympathetic nervous system development	1	15	6.66666666666667	0.0748229031998671	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
7291;	GO:0048511	rhythmic process	1	54	1.85185185185185	0.234777398326665	0.264537913607509	1	1	0.907423808073593	0.907423808073593	1
57124;	GO:0048535	lymph node development	1	17	5.88235294117647	0.083777116024585	0.123923006754394	1	1	0.907423808073593	0.907423808073593	0.92256585255994
2625;	GO:0048538	thymus development	1	42	2.38095238095238	0.188721967914471	0.219337880384858	1	1	0.907423808073593	0.907423808073593	1
6422; 6423;	GO:0048546	digestive tract morphogenesis	2	12	16.6666666666667	0.00203778608079697	0.0216852801389006	1	1	0.425897290886566	0.907423808073593	0.161439747818551
2737;	GO:0048557	embryonic digestive tract morphogenesis	1	19	5.26315789473684	0.0926455249139971	0.130601621024137	1	1	0.907423808073593	0.907423808073593	0.972285929800287
1281; 7043; 2625;	GO:0048565	digestive tract development	3	38	7.89473684210526	0.00103046012330221	0.0137394683106962	0.916079049615667	0.989241718370124	0.326599007917632	0.907423808073593	0.102285803320603
2737;	GO:0048566	embryonic digestive tract development	1	15	6.66666666666667	0.0748229031998671	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
2737; 2625; 2619;	GO:0048589	developmental growth	3	22	13.6363636363636	0.000235183081189971	0.0053756132843422	0.216368434694774	0.225775757942372	0.153574552017051	0.216133251613584	0.0400196652953295
1290; 1289;	GO:0048592	eye morphogenesis	2	3	66.6666666666667	0.000230400979116863	0.0053756132843422	0.212429702745747	0.221184939952188	0.151691151877005	0.21219930176663	0.0400196652953295
2737;	GO:0048593	camera-type eye morphogenesis	1	17	5.88235294117647	0.083777116024585	0.123923006754394	1	1	0.907423808073593	0.907423808073593	0.92256585255994
7291;	GO:0048642	negative regulation of skeletal muscle tissue development	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
2625;	GO:0048646	anatomical structure formation involved in morphogenesis	1	12	8.33333333333333	0.0612289019715984	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
347;	GO:0048662	negative regulation of smooth muscle cell proliferation	1	28	3.57142857142857	0.131513187863543	0.167443846616713	1	1	0.907423808073593	0.907423808073593	1
5396;	GO:0048664	neuron fate determination	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
1382;	GO:0048672	positive regulation of collateral sprouting	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
3776; 347; 3956;	GO:0048678	response to axon injury	3	26	11.5384615384615	0.000368415769071984	0.00707358276618208	0.335626765624577	0.353679138309104	0.195260357608151	0.335626765624577	0.0526604872351896
146760;	GO:0048681	negative regulation of axon regeneration	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
5396; 7291;	GO:0048701	embryonic cranial skeleton morphogenesis	2	32	6.25	0.0117962456659022	0.0574842428389143	1	1	0.735539350479731	0.907423808073593	0.427951200446202
7043;	GO:0048702	embryonic neurocranium morphogenesis	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
2737; 1301;	GO:0048704	embryonic skeletal system morphogenesis	2	38	5.26315789473684	0.0160958679392817	0.0623065855714132	1	1	0.799020555427036	0.907423808073593	0.463851949232596
2260;	GO:0048705	skeletal system morphogenesis	1	29	3.44827586206897	0.135728733985959	0.170549194537331	1	1	0.907423808073593	0.907423808073593	1
1277; 3223; 23213;	GO:0048706	embryonic skeletal system development	3	28	10.7142857142857	0.000450035680721328	0.00785516824531772	0.408632398094966	0.432034253492475	0.218121745549945	0.407732326733523	0.0584791329636324
2737;	GO:0048709	oligodendrocyte differentiation	1	26	3.84615384615385	0.123020933257398	0.160462086857476	1	1	0.907423808073593	0.907423808073593	1
2260;	GO:0048762	mesenchymal cell differentiation	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
7060;	GO:0048771	tissue remodeling	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
6678; 7043;	GO:0048839	inner ear development	2	45	4.44444444444444	0.0218246625398212	0.0671828519880796	1	1	0.846506290332147	0.907423808073593	0.500154142036207
348; 5396;	GO:0048844	artery morphogenesis	2	21	9.52380952380952	0.00550695232643139	0.0440556186114511	1	1	0.589243898928159	0.907423808073593	0.327979528651066
6678;	GO:0048856	anatomical structure development	1	23	4.34782608695652	0.110128179209321	0.148696275725666	1	1	0.907423808073593	0.907423808073593	1
2099;	GO:0048863	stem cell differentiation	1	28	3.57142857142857	0.131513187863543	0.167443846616713	1	1	0.907423808073593	0.907423808073593	1
5167;	GO:0050427	3'-phosphoadenosine 5'-phosphosulfate metabolic process	1	19	5.26315789473684	0.0926455249139971	0.130601621024137	1	1	0.907423808073593	0.907423808073593	0.972285929800287
7291; 6422;	GO:0050679	positive regulation of epithelial cell proliferation	2	57	3.50877192982456	0.033277343033694	0.078119488901253	1	1	0.898488261909738	0.907423808073593	0.581573791399117
6422; 6423;	GO:0050680	negative regulation of epithelial cell proliferation	2	57	3.50877192982456	0.033277343033694	0.078119488901253	1	1	0.898488261909738	0.907423808073593	0.581573791399117
7043;	GO:0050714	positive regulation of protein secretion	1	38	2.63157894736842	0.172768500433013	0.205778859076542	1	1	0.907423808073593	0.907423808073593	1
6363;	GO:0050718	positive regulation of interleukin-1 beta secretion	1	26	3.84615384615385	0.123020933257398	0.160462086857476	1	1	0.907423808073593	0.907423808073593	1
2099;	GO:0050727	regulation of inflammatory response	1	79	1.26582278481013	0.32257521705971	0.341424706038943	1	1	0.907423808073593	0.907423808073593	1
348; 2625; 5176; 5740;	GO:0050728	negative regulation of inflammatory response	4	94	4.25531914893617	0.00132443430683082	0.0165124277215272	1	1	0.364219434378477	0.907423808073593	0.122929570204323
7060;	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	1	85	1.17647058823529	0.342116389181948	0.359728076248269	1	1	0.907423808073593	0.907423808073593	1
6422; 6423;	GO:0050732	negative regulation of peptidyl-tyrosine phosphorylation	2	11	18.1818181818182	0.001752200990219	0.0200251541739314	1	1	0.40763326244916	0.907423808073593	0.149080658361788
4240;	GO:0050766	positive regulation of phagocytosis	1	35	2.85714285714286	0.160599945882917	0.194666601070202	1	1	0.907423808073593	0.907423808073593	1
5176;	GO:0050769	positive regulation of neurogenesis	1	21	4.76190476190476	0.101428943859667	0.13950112622533	1	1	0.907423808073593	0.907423808073593	1
1277; 1281; 1278; 81035;	GO:0050776	regulation of immune response	4	206	1.94174757281553	0.0191631387240001	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
1281;	GO:0050777	negative regulation of immune response	1	28	3.57142857142857	0.131513187863543	0.167443846616713	1	1	0.907423808073593	0.907423808073593	1
2625;	GO:0050852	T cell receptor signaling pathway	1	172	0.581395348837209	0.570062317716343	0.579110925934062	1	1	0.907423808073593	0.907423808073593	1
10457;	GO:0050868	negative regulation of T cell activation	1	12	8.33333333333333	0.0612289019715984	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
1277; 2335; 1278; 4318;	GO:0050900	leukocyte migration	4	206	1.94174757281553	0.0191631387240001	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
1301;	GO:0050910	detection of mechanical stimulus involved in sensory perception of sound	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
10457;	GO:0050918	positive chemotaxis	1	39	2.56410256410256	0.176785747420046	0.209265496329524	1	1	0.907423808073593	0.907423808073593	1
6363;	GO:0050921	positive regulation of chemotaxis	1	12	8.33333333333333	0.0612289019715984	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
348;	GO:0051000	positive regulation of nitric-oxide synthase activity	1	19	5.26315789473684	0.0926455249139971	0.130601621024137	1	1	0.907423808073593	0.907423808073593	0.972285929800287
348;	GO:0051044	positive regulation of membrane protein ectodomain proteolysis	1	15	6.66666666666667	0.0748229031998671	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
7077;	GO:0051045	negative regulation of membrane protein ectodomain proteolysis	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
2099;	GO:0051091	positive regulation of DNA binding transcription factor activity	1	110	0.909090909090909	0.417706077839979	0.433043018063045	1	1	0.907423808073593	0.907423808073593	1
1289;	GO:0051128	regulation of cellular component organization	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
6363;	GO:0051209	release of sequestered calcium ion into cytosol	1	36	2.77777777777778	0.164675692686062	0.198603850475652	1	1	0.907423808073593	0.907423808073593	1
4060; 5396; 23213;	GO:0051216	cartilage development	3	58	5.17241379310345	0.00324387792104797	0.0288344704093153	1	1	0.490488907873286	0.907423808073593	0.21466310794901
348;	GO:0051246	regulation of protein metabolic process	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
81035;	GO:0051260	protein homooligomerization	1	202	0.495049504950495	0.628876735569522	0.63616613924841	1	1	0.907423808073593	0.907423808073593	1
23194;	GO:0051301	cell division	1	350	0.285714285714286	0.820956803842251	0.824391769548704	1	1	0.907423808073593	0.907423808073593	1
6678;	GO:0051384	response to glucocorticoid	1	57	1.75438596491228	0.245880816677305	0.274471609314201	1	1	0.907423808073593	0.907423808073593	1
7060;	GO:0051451	myoblast migration	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
7043;	GO:0051491	positive regulation of filopodium assembly	1	29	3.44827586206897	0.135728733985959	0.170549194537331	1	1	0.907423808073593	0.907423808073593	1
7043; 6422;	GO:0051496	positive regulation of stress fiber assembly	2	47	4.25531914893617	0.0235950069126583	0.0671828519880796	1	1	0.853289193299553	0.907423808073593	0.500154142036207
4318;	GO:0051549	positive regulation of keratinocyte migration	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
2625;	GO:0051569	regulation of histone H3-K4 methylation	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
1277; 6678;	GO:0051591	response to cAMP	2	45	4.44444444444444	0.0218246625398212	0.0671828519880796	1	1	0.846506290332147	0.907423808073593	0.500154142036207
6678;	GO:0051592	response to calcium ion	1	53	1.88679245283019	0.231040412431932	0.261555183885205	1	1	0.907423808073593	0.907423808073593	1
1513; 2191;	GO:0051603	proteolysis involved in cellular protein catabolic process	2	32	6.25	0.0117962456659022	0.0574842428389143	1	1	0.735539350479731	0.907423808073593	0.427951200446202
348;	GO:0051651	maintenance of location in cell	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
2335;	GO:0051702	interaction with symbiont	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
7043; 7060;	GO:0051781	positive regulation of cell division	2	47	4.25531914893617	0.0235950069126583	0.0671828519880796	1	1	0.853289193299553	0.907423808073593	0.500154142036207
6422;	GO:0051894	positive regulation of focal adhesion assembly	1	24	4.16666666666667	0.114446477946567	0.152807536618504	1	1	0.907423808073593	0.907423808073593	1
347;	GO:0051895	negative regulation of focal adhesion assembly	1	15	6.66666666666667	0.0748229031998671	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
2099; 2260; 2625; 56917; 6363;	GO:0051897	positive regulation of protein kinase B signaling	5	147	3.40136054421769	0.000871987561847143	0.0128785855288193	0.78130085541504	0.837108059373257	0.302579683960959	0.78130085541504	0.0958768153657638
1634;	GO:0051901	positive regulation of mitochondrial depolarization	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
2191;	GO:0051917	regulation of fibrinolysis	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
4920;	GO:0051968	positive regulation of synaptic transmission, glutamatergic	1	27	3.7037037037037	0.127277286716657	0.164449791720041	1	1	0.907423808073593	0.907423808073593	1
2335;	GO:0052047	interaction with other organism via secreted substance involved in symbiotic interaction	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
1301;	GO:0055010	ventricular cardiac muscle tissue morphogenesis	1	25	4	0.118744029737539	0.156370738749023	1	1	0.907423808073593	0.907423808073593	1
6424;	GO:0055062	phosphate ion homeostasis	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
348;	GO:0055089	fatty acid homeostasis	1	13	7.69230769230769	0.065782064732448	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
1277;	GO:0055093	response to hyperoxia	1	12	8.33333333333333	0.0612289019715984	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
4016; 5740;	GO:0055114	oxidation-reduction process	2	535	0.373831775700935	0.737979842853667	0.741843611664419	1	1	0.907423808073593	0.907423808073593	1
2625;	GO:0060017	parathyroid gland development	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
7431;	GO:0060020	Bergmann glial cell differentiation	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
2737; 5396; 7291;	GO:0060021	roof of mouth development	3	62	4.83870967741935	0.00388241936202949	0.032983385730516	1	1	0.518885634118582	0.907423808073593	0.245550412096565
6423;	GO:0060028	convergent extension involved in axis elongation	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
57124;	GO:0060033	anatomical structure regression	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
2625;	GO:0060037	pharyngeal system development	1	18	5.55555555555556	0.0882219949067566	0.127358067835318	1	1	0.907423808073593	0.907423808073593	0.948138747680206
5176;	GO:0060041	retina development in camera-type eye	1	55	1.81818181818182	0.238496403972345	0.268099002123479	1	1	0.907423808073593	0.907423808073593	1
3776;	GO:0060044	negative regulation of cardiac muscle cell proliferation	1	12	8.33333333333333	0.0612289019715984	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
2260;	GO:0060045	positive regulation of cardiac muscle cell proliferation	1	23	4.34782608695652	0.110128179209321	0.148696275725666	1	1	0.907423808073593	0.907423808073593	1
2099; 2625;	GO:0060065	uterus development	2	15	13.3333333333333	0.00301677393088262	0.0273217261664841	1	1	0.480696933305943	0.907423808073593	0.203401226732242
2099;	GO:0060068	vagina development	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
6422; 6424; 6423;	GO:0060070	canonical Wnt signaling pathway	3	88	3.40909090909091	0.00986419514344039	0.0512177962421144	1	1	0.6989111848785	0.907423808073593	0.38129957538875
4920; 115908;	GO:0060071	Wnt signaling pathway, planar cell polarity pathway	2	93	2.1505376344086	0.0777148833792574	0.119945800713966	1	1	0.907423808073593	0.907423808073593	0.892956867290839
2260;	GO:0060117	auditory receptor cell development	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
115908;	GO:0060122	inner ear receptor cell stereocilium organization	1	15	6.66666666666667	0.0748229031998671	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
1311;	GO:0060173	limb development	1	28	3.57142857142857	0.131513187863543	0.167443846616713	1	1	0.907423808073593	0.907423808073593	1
8076;	GO:0060216	definitive hemopoiesis	1	16	6.25	0.0793107862791833	0.120092042315483	1	1	0.907423808073593	0.907423808073593	0.894045587709397
6422;	GO:0060218	hematopoietic stem cell differentiation	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
2625;	GO:0060231	mesenchymal to epithelial transition	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
8406; 2191;	GO:0060244	negative regulation of cell proliferation involved in contact inhibition	2	4	50	0.000344508113106268	0.00674954670575545	0.315569431605341	0.330727788582017	0.188735121386135	0.314191399152916	0.0502481457969275
1277; 4313; 7043;	GO:0060325	face morphogenesis	3	31	9.67741935483871	0.000592833255952829	0.00981241251232269	0.535921263381358	0.569119925714716	0.251898305432457	0.535328430125405	0.0730501700385819
1277; 4313; 6422;	GO:0060346	bone trabecula formation	3	8	37.5	1.77247925908786e-05	0.000945322271513523	0.0167144794131985	0.0170158008872434	0.0164840571095171	0.0167144794131985	0.00703761206416863
6678; 23213;	GO:0060348	bone development	2	42	4.76190476190476	0.0192788195772527	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
6424; 6423;	GO:0060349	bone morphogenesis	2	26	7.69230769230769	0.00809938985783121	0.0507325338260943	1	1	0.663981502762809	0.907423808073593	0.377686956987405
1277;	GO:0060351	cartilage development involved in endochondral bone morphogenesis	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
81035;	GO:0060355	positive regulation of cell adhesion molecule production	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
7291;	GO:0060363	cranial suture morphogenesis	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
2737; 7043;	GO:0060364	frontal suture morphogenesis	2	4	50	0.000344508113106268	0.00674954670575545	0.315569431605341	0.330727788582017	0.188735121386135	0.314191399152916	0.0502481457969275
2737;	GO:0060366	lambdoid suture morphogenesis	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
2737;	GO:0060367	sagittal suture morphogenesis	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
2625;	GO:0060374	mast cell differentiation	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
23213;	GO:0060384	innervation	1	19	5.26315789473684	0.0926455249139971	0.130601621024137	1	1	0.907423808073593	0.907423808073593	0.972285929800287
7043;	GO:0060391	positive regulation of SMAD protein signal transduction	1	12	8.33333333333333	0.0612289019715984	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
7431; 7043; 4920;	GO:0060395	SMAD protein signal transduction	3	56	5.35714285714286	0.00295066310908987	0.0272368902377526	1	1	0.478007423672559	0.907423808073593	0.202769651264799
1281;	GO:0060414	aorta smooth muscle tissue morphogenesis	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
2260;	GO:0060445	branching involved in salivary gland morphogenesis	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
2260;	GO:0060484	lung-associated mesenchyme development	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
6363;	GO:0060491	regulation of cell projection assembly	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
2099;	GO:0060523	prostate epithelial cord elongation	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
2099; 6422;	GO:0060527	prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis	2	6	33.3333333333333	0.000639021504395654	0.0100047299011488	0.57639739696488	0.613460644219828	0.260720773793427	0.575119353956088	0.0744819094744729
8839;	GO:0060548	negative regulation of cell death	1	59	1.69491525423729	0.253194330840938	0.280030596321775	1	1	0.907423808073593	0.907423808073593	1
347;	GO:0060588	negative regulation of lipoprotein lipid oxidation	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
2737;	GO:0060594	mammary gland specification	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
2619;	GO:0060628	regulation of ER to Golgi vesicle-mediated transport	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
2260;	GO:0060665	regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
2625;	GO:0060676	ureteric bud formation	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
23213;	GO:0060686	negative regulation of prostatic bud formation	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
2099; 6422;	GO:0060687	regulation of branching involved in prostate gland morphogenesis	2	7	28.5714285714286	0.000819002667354796	0.0122850400103219	0.734645392617252	0.786242560660604	0.293202954913017	0.734645392617252	0.0914580650332209
2099;	GO:0060745	mammary gland branching involved in pregnancy	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
2099;	GO:0060749	mammary gland alveolus development	1	15	6.66666666666667	0.0748229031998671	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
2099;	GO:0060750	epithelial cell proliferation involved in mammary gland duct elongation	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
6422;	GO:0060766	negative regulation of androgen receptor signaling pathway	1	12	8.33333333333333	0.0612289019715984	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
5176;	GO:0060770	negative regulation of epithelial cell proliferation involved in prostate gland development	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
2737;	GO:0060831	smoothened signaling pathway involved in dorsal/ventral neural tube patterning	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
2737;	GO:0060840	artery development	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
2737;	GO:0060873	anterior semicircular canal development	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
2737;	GO:0060875	lateral semicircular canal development	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
7291;	GO:0060900	embryonic camera-type eye formation	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
348;	GO:0060999	positive regulation of dendritic spine development	1	21	4.76190476190476	0.101428943859667	0.13950112622533	1	1	0.907423808073593	0.907423808073593	1
2737;	GO:0061005	cell differentiation involved in kidney development	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
7291;	GO:0061029	eyelid development in camera-type eye	1	13	7.69230769230769	0.065782064732448	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
6423;	GO:0061056	sclerotome development	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
60681;	GO:0061077	chaperone-mediated protein folding	1	54	1.85185185185185	0.234777398326665	0.264537913607509	1	1	0.907423808073593	0.907423808073593	1
2625;	GO:0061085	regulation of histone H3-K27 methylation	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
6423;	GO:0061185	negative regulation of dermatome development	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
2625;	GO:0061290	canonical Wnt signaling pathway involved in metanephric kidney development	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
348;	GO:0061771	response to caloric restriction	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
7043;	GO:0062009	secondary palate development	1	13	7.69230769230769	0.065782064732448	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
26471;	GO:0065003	protein-containing complex assembly	1	116	0.862068965517241	0.434528150027209	0.449996789672191	1	1	0.907423808073593	0.907423808073593	1
6363;	GO:0070098	chemokine-mediated signaling pathway	1	71	1.40845070422535	0.295623843972797	0.318875157543691	1	1	0.907423808073593	0.907423808073593	1
11117;	GO:0070207	protein homotrimerization	1	28	3.57142857142857	0.131513187863543	0.167443846616713	1	1	0.907423808073593	0.907423808073593	1
1277; 1278; 1291; 1292;	GO:0070208	protein heterotrimerization	4	10	40	5.01095589133804e-07	4.81051765568452e-05	0.000476541905266248	0.000481051765568452	0.000476541905266248	0.000476541905266248	0.00035812714995425
2737;	GO:0070242	thymocyte apoptotic process	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
7431;	GO:0070307	lens fiber cell development	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
348;	GO:0070328	triglyceride homeostasis	1	25	4	0.118744029737539	0.156370738749023	1	1	0.907423808073593	0.907423808073593	1
2335;	GO:0070372	regulation of ERK1 and ERK2 cascade	1	27	3.7037037037037	0.127277286716657	0.164449791720041	1	1	0.907423808073593	0.907423808073593	1
2192;	GO:0070373	negative regulation of ERK1 and ERK2 cascade	1	60	1.66666666666667	0.256824711810009	0.283392785445527	1	1	0.907423808073593	0.907423808073593	1
10457; 6363; 2260; 4920;	GO:0070374	positive regulation of ERK1 and ERK2 cascade	4	228	1.75438596491228	0.0264311677348207	0.0725955692646671	1	1	0.869761957648965	0.907423808073593	0.540450034298067
7043;	GO:0070483	detection of hypoxia	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
10398;	GO:0070527	platelet aggregation	1	42	2.38095238095238	0.188721967914471	0.219337880384858	1	1	0.907423808073593	0.907423808073593	1
5396;	GO:0070570	regulation of neuron projection regeneration	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
2260;	GO:0070640	vitamin D3 metabolic process	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
4060;	GO:0070848	response to growth factor	1	14	7.14285714285714	0.0703133638315967	0.112689197459654	1	1	0.907423808073593	0.907423808073593	0.838933852974602
29995;	GO:0070886	positive regulation of calcineurin-NFAT signaling cascade	1	14	7.14285714285714	0.0703133638315967	0.112689197459654	1	1	0.907423808073593	0.907423808073593	0.838933852974602
2191;	GO:0071158	positive regulation of cell cycle arrest	1	26	3.84615384615385	0.123020933257398	0.160462086857476	1	1	0.907423808073593	0.907423808073593	1
2099;	GO:0071168	protein localization to chromatin	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
1277; 1281; 1290; 1278; 4313; 1291;	GO:0071230	cellular response to amino acid stimulus	6	50	12	2.97421797634811e-07	3.17249917477132e-05	0.000283145551348341	0.000285524925729419	0.000282848129550706	0.000283145551348341	0.000236182084551853
1277;	GO:0071260	cellular response to mechanical stimulus	1	77	1.2987012987013	0.315934651102408	0.335135099511947	1	1	0.907423808073593	0.907423808073593	1
4318;	GO:0071276	cellular response to cadmium ion	1	38	2.63157894736842	0.172768500433013	0.205778859076542	1	1	0.907423808073593	0.907423808073593	1
5176;	GO:0071279	cellular response to cobalt ion	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
1277; 5176;	GO:0071300	cellular response to retinoic acid	2	68	2.94117647058824	0.0453952582139219	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
6422;	GO:0071305	cellular response to vitamin D	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
1277;	GO:0071306	cellular response to vitamin E	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
10631;	GO:0071307	cellular response to vitamin K	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
3956; 5176;	GO:0071333	cellular response to glucose stimulus	2	59	3.38983050847458	0.0353714726932608	0.0822194038390566	1	1	0.907423808073592	0.907423808073593	0.612096303877486
7431; 6363;	GO:0071346	cellular response to interferon-gamma	2	89	2.24719101123596	0.0721539265635835	0.115254192181431	1	1	0.907423808073593	0.907423808073593	0.85802939144066
5740; 6422; 6363;	GO:0071347	cellular response to interleukin-1	3	76	3.94736842105263	0.00669425267748525	0.0507325338260943	1	1	0.635910740044381	0.907423808073593	0.377686956987405
2625;	GO:0071353	cellular response to interleukin-4	1	24	4.16666666666667	0.114446477946567	0.152807536618504	1	1	0.907423808073593	0.907423808073593	1
5740;	GO:0071354	cellular response to interleukin-6	1	15	6.66666666666667	0.0748229031998671	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
1277; 2625; 10631; 6422; 6363;	GO:0071356	cellular response to tumor necrosis factor	5	122	4.0983606557377	0.000385380078325115	0.00725421323906099	0.350695871275855	0.36996487519211	0.200012260650735	0.350695871275855	0.0540052214421323
81035;	GO:0071360	cellular response to exogenous dsRNA	1	15	6.66666666666667	0.0748229031998671	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
6678; 7291; 6422;	GO:0071363	cellular response to growth factor stimulus	3	44	6.81818181818182	0.0015348294777402	0.0184179537328824	1	1	0.390672018096143	0.907423808073593	0.1371155819489
1277;	GO:0071364	cellular response to epidermal growth factor stimulus	1	39	2.56410256410256	0.176785747420046	0.209265496329524	1	1	0.907423808073593	0.907423808073593	1
6422;	GO:0071380	cellular response to prostaglandin E stimulus	1	17	5.88235294117647	0.083777116024585	0.123923006754394	1	1	0.907423808073593	0.907423808073593	0.92256585255994
2099; 6422;	GO:0071391	cellular response to estrogen stimulus	2	13	15.3846153846154	0.00234387734465391	0.0234387734465391	1	1	0.443603280041521	0.907423808073593	0.174493926301533
2099; 6422;	GO:0071392	cellular response to estradiol stimulus	2	35	5.71428571428571	0.0138730609680048	0.0581497223322038	1	1	0.767059733209955	0.907423808073593	0.432905475460724
3956;	GO:0071407	cellular response to organic cyclic compound	1	50	2	0.219720710746885	0.249623529369243	1	1	0.907423808073593	0.907423808073593	1
6423;	GO:0071425	hematopoietic stem cell proliferation	1	13	7.69230769230769	0.065782064732448	0.107765839834727	1	1	0.907423808073593	0.907423808073593	0.802281081680079
2625;	GO:0071442	positive regulation of histone H3-K14 acetylation	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
3776; 7291; 5740; 6422;	GO:0071456	cellular response to hypoxia	4	107	3.73831775700935	0.00209316424295003	0.0218417138394786	1	1	0.429098669804756	0.907423808073593	0.162604345048094
6422; 6423;	GO:0071481	cellular response to X-ray	2	11	18.1818181818182	0.001752200990219	0.0200251541739314	1	1	0.40763326244916	0.907423808073593	0.149080658361788
6422;	GO:0071504	cellular response to heparin	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
4010; 6422;	GO:0071542	dopaminergic neuron differentiation	2	21	9.52380952380952	0.00550695232643139	0.0440556186114511	1	1	0.589243898928159	0.907423808073593	0.327979528651066
5176;	GO:0071549	cellular response to dexamethasone stimulus	1	31	3.2258064516129	0.144099148021041	0.178037557400514	1	1	0.907423808073593	0.907423808073593	1
25878;	GO:0071559	response to transforming growth factor beta	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
1277; 10631; 6422;	GO:0071560	cellular response to transforming growth factor beta stimulus	3	53	5.66037735849057	0.00254250433739001	0.0248879842214216	1	1	0.455108276392811	0.907423808073593	0.185282821835018
2625;	GO:0071599	otic vesicle development	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
7060;	GO:0071603	endothelial cell-cell adhesion	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
347;	GO:0071638	negative regulation of monocyte chemotactic protein-1 production	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
7291;	GO:0071639	positive regulation of monocyte chemotactic protein-1 production	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
4320;	GO:0071711	basement membrane organization	1	10	10	0.0520565672824588	0.0955531636542264	1	1	0.907423808073593	0.907423808073593	0.711361741457546
6363;	GO:0071731	response to nitric oxide	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
2625; 6422;	GO:0071773	cellular response to BMP stimulus	2	32	6.25	0.0117962456659022	0.0574842428389143	1	1	0.735539350479731	0.907423808073593	0.427951200446202
3776;	GO:0071805	potassium ion transmembrane transport	1	131	0.763358778625954	0.474507545429751	0.488239275040258	1	1	0.907423808073593	0.907423808073593	1
2191;	GO:0071850	mitotic cell cycle arrest	1	15	6.66666666666667	0.0748229031998671	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
2625;	GO:0072107	positive regulation of ureteric bud formation	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
59;	GO:0072144	glomerular mesangial cell development	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
2625;	GO:0072178	nephric duct morphogenesis	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
2625;	GO:0072179	nephric duct formation	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
2625;	GO:0072182	regulation of nephron tubule epithelial cell differentiation	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
2192;	GO:0072378	blood coagulation, fibrin clot formation	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
2625;	GO:0072602	interleukin-4 secretion	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
6363;	GO:0072610	interleukin-12 secretion	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
2625;	GO:0072643	interferon-gamma secretion	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
2625;	GO:0072676	lymphocyte migration	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
7060; 6363;	GO:0090023	positive regulation of neutrophil chemotaxis	2	30	6.66666666666667	0.0104951125901793	0.0533085083945616	1	1	0.711215959260163	0.907423808073593	0.396864236785343
2260;	GO:0090080	positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
348; 2737; 4920; 6424; 6422; 115908; 6423;	GO:0090090	negative regulation of canonical Wnt signaling pathway	7	167	4.19161676646707	2.22691068191283e-05	0.0011251759234928	0.0209774986236189	0.0213783425463632	0.0205989238076937	0.0209774986236189	0.00837656309610359
3776; 2625;	GO:0090102	cochlea development	2	26	7.69230769230769	0.00809938985783121	0.0507325338260943	1	1	0.663981502762809	0.907423808073593	0.377686956987405
115908;	GO:0090103	cochlea morphogenesis	1	24	4.16666666666667	0.114446477946567	0.152807536618504	1	1	0.907423808073593	0.907423808073593	1
59;	GO:0090131	mesenchyme migration	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
1634;	GO:0090141	positive regulation of mitochondrial fission	1	15	6.66666666666667	0.0748229031998671	0.116001512662042	1	1	0.907423808073593	0.907423808073593	0.863592945573081
115908;	GO:0090177	establishment of planar polarity involved in neural tube closure	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
6422; 6423;	GO:0090179	planar cell polarity pathway involved in neural tube closure	2	13	15.3846153846154	0.00234387734465391	0.0234387734465391	1	1	0.443603280041521	0.907423808073593	0.174493926301533
348;	GO:0090181	regulation of cholesterol metabolic process	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
4318;	GO:0090200	positive regulation of release of cytochrome c from mitochondria	1	29	3.44827586206897	0.135728733985959	0.170549194537331	1	1	0.907423808073593	0.907423808073593	1
348;	GO:0090209	negative regulation of triglyceride metabolic process	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
6422; 6423;	GO:0090244	Wnt signaling pathway involved in somitogenesis	2	4	50	0.000344508113106268	0.00674954670575545	0.315569431605341	0.330727788582017	0.188735121386135	0.314191399152916	0.0502481457969275
6422;	GO:0090246	convergent extension involved in somitogenesis	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
1277; 4920; 6424; 6422; 6423;	GO:0090263	positive regulation of canonical Wnt signaling pathway	5	139	3.59712230215827	0.000683439185659274	0.0104143114005223	0.613728388722028	0.656101618232903	0.269076134219385	0.613728388722028	0.0775311084493749
2260;	GO:0090272	negative regulation of fibroblast growth factor production	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
5167;	GO:0090305	nucleic acid phosphodiester bond hydrolysis	1	77	1.2987012987013	0.315934651102408	0.335135099511947	1	1	0.907423808073593	0.907423808073593	1
6363;	GO:0097029	mature conventional dendritic cell differentiation	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
348;	GO:0097113	AMPA glutamate receptor clustering	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
348;	GO:0097114	NMDA glutamate receptor clustering	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
5396;	GO:0097150	neuronal stem cell population maintenance	1	22	4.54545454545455	0.105789034383918	0.144257774159888	1	1	0.907423808073593	0.907423808073593	1
5740;	GO:0097190	apoptotic signaling pathway	1	76	1.31578947368421	0.312590242434654	0.332690280196528	1	1	0.907423808073593	0.907423808073593	1
2191;	GO:0097325	melanocyte proliferation	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
2737;	GO:0097421	liver regeneration	1	34	2.94117647058824	0.156504512363655	0.190907664382603	1	1	0.907423808073593	0.907423808073593	1
1281; 1289; 8076;	GO:0097435	supramolecular fiber organization	3	13	23.0769230769231	5.91056073587781e-05	0.00257915377565577	0.0555001653098927	0.056741383064427	0.0533132578376179	0.0555001653098927	0.0192009479453394
6363;	GO:0098586	cellular response to virus	1	21	4.76190476190476	0.101428943859667	0.13950112622533	1	1	0.907423808073593	0.907423808073593	1
348;	GO:0098869	cellular oxidant detoxification	1	72	1.38888888888889	0.299049964679206	0.321127478850154	1	1	0.907423808073593	0.907423808073593	1
347;	GO:1900016	negative regulation of cytokine production involved in inflammatory response	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
4920;	GO:1900020	positive regulation of protein kinase C activity	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
2192; 10631;	GO:1900025	negative regulation of substrate adhesion-dependent cell spreading	2	13	15.3846153846154	0.00234387734465391	0.0234387734465391	1	1	0.443603280041521	0.907423808073593	0.174493926301533
3776;	GO:1900039	positive regulation of cellular response to hypoxia	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
2191; 5740;	GO:1900119	positive regulation of execution phase of apoptosis	2	8	25	0.0010205192546171	0.0137394683106962	0.909282655863838	0.979698484432419	0.325181690439646	0.907423808073593	0.102285803320603
4318;	GO:1900122	positive regulation of receptor binding	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
348;	GO:1900221	regulation of amyloid-beta clearance	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
348;	GO:1900272	negative regulation of long-term synaptic potentiation	1	8	12.5	0.0427955184494293	0.087226534419219	1	1	0.907423808073593	0.907423808073593	0.649372737152881
1634;	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
348; 5176; 10457;	GO:1901215	negative regulation of neuron death	3	44	6.81818181818182	0.0015348294777402	0.0184179537328824	1	1	0.390672018096143	0.907423808073593	0.1371155819489
6363;	GO:1901224	positive regulation of NIK/NF-kappaB signaling	1	49	2.04081632653061	0.215910939303833	0.246461952118526	1	1	0.907423808073593	0.907423808073593	1
2625;	GO:1901536	negative regulation of DNA demethylation	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
348;	GO:1901628	positive regulation of postsynaptic membrane organization	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
348;	GO:1901630	negative regulation of presynaptic membrane organization	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
2625;	GO:1902036	regulation of hematopoietic stem cell differentiation	1	74	1.35135135135135	0.305852787818102	0.325880883801751	1	1	0.907423808073593	0.907423808073593	1
6423;	GO:1902042	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	1	35	2.85714285714286	0.160599945882917	0.194666601070202	1	1	0.907423808073593	0.907423808073593	1
6422;	GO:1902043	positive regulation of extrinsic apoptotic signaling pathway via death domain receptors	1	14	7.14285714285714	0.0703133638315967	0.112689197459654	1	1	0.907423808073593	0.907423808073593	0.838933852974602
6424;	GO:1902174	positive regulation of keratinocyte apoptotic process	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
6423;	GO:1902230	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	1	16	6.25	0.0793107862791833	0.120092042315483	1	1	0.907423808073593	0.907423808073593	0.894045587709397
2191;	GO:1902362	melanocyte apoptotic process	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
348;	GO:1902430	negative regulation of amyloid-beta formation	1	9	11.1111111111111	0.0474371850266357	0.0912619190893193	1	1	0.907423808073593	0.907423808073593	0.679414843103045
1277;	GO:1902618	cellular response to fluoride	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
348;	GO:1902952	positive regulation of dendritic spine maintenance	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
348;	GO:1902995	positive regulation of phospholipid efflux	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
348;	GO:1903002	positive regulation of lipid transport across blood brain barrier	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
2737;	GO:1903010	regulation of bone development	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
2191;	GO:1903054	negative regulation of extracellular matrix organization	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
131578;	GO:1903077	negative regulation of protein localization to plasma membrane	1	18	5.55555555555556	0.0882219949067566	0.127358067835318	1	1	0.907423808073593	0.907423808073593	0.948138747680206
1290; 1289;	GO:1903225	negative regulation of endodermal cell differentiation	2	2	100	0.000138679476933246	0.00416038430799737	0.129110593024852	0.133132297855916	0.109140748346464	0.128833234070985	0.0309726869659616
2260;	GO:1903465	positive regulation of mitotic cell cycle DNA replication	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
3223;	GO:1903507	negative regulation of nucleic acid-templated transcription	1	47	2.12765957446809	0.208236064581996	0.238837063319852	1	1	0.907423808073593	0.907423808073593	1
2099;	GO:1903799	negative regulation of production of miRNAs involved in gene silencing by miRNA	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
10631;	GO:1904209	positive regulation of chemokine (C-C motif) ligand 2 secretion	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
2335;	GO:1904237	positive regulation of substrate-dependent cell migration, cell attachment to substrate	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
7043;	GO:1904706	negative regulation of vascular smooth muscle cell proliferation	1	17	5.88235294117647	0.083777116024585	0.123923006754394	1	1	0.907423808073593	0.907423808073593	0.92256585255994
4313; 4318;	GO:1904707	positive regulation of vascular smooth muscle cell proliferation	2	27	7.40740740740741	0.00867205460520437	0.0507325338260943	1	1	0.675150241244942	0.907423808073593	0.377686956987405
6422; 6423;	GO:1904956	regulation of midbrain dopaminergic neuron differentiation	2	2	100	0.000138679476933246	0.00416038430799737	0.129110593024852	0.133132297855916	0.109140748346464	0.128833234070985	0.0309726869659616
7043;	GO:1905005	regulation of epithelial to mesenchymal transition involved in endocardial cushion formation	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
7077;	GO:1905049	negative regulation of metallopeptidase activity	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
7043;	GO:1905075	positive regulation of occluding junction disassembly	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
4920;	GO:1905517	macrophage migration	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
2260;	GO:1905564	positive regulation of vascular endothelial cell proliferation	1	14	7.14285714285714	0.0703133638315967	0.112689197459654	1	1	0.907423808073593	0.907423808073593	0.838933852974602
348;	GO:1905855	positive regulation of heparan sulfate binding	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
348;	GO:1905860	positive regulation of heparan sulfate proteoglycan binding	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
348;	GO:1905890	regulation of cellular response to very-low-density lipoprotein particle stimulus	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
348;	GO:1905906	regulation of amyloid fibril formation	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
348;	GO:1905908	positive regulation of amyloid fibril formation	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
10631;	GO:1990138	neuron projection extension	1	18	5.55555555555556	0.0882219949067566	0.127358067835318	1	1	0.907423808073593	0.907423808073593	0.948138747680206
10631;	GO:1990523	bone regeneration	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
5118;	GO:1990830	cellular response to leukemia inhibitory factor	1	91	1.0989010989011	0.361099347045361	0.378032031803213	1	1	0.907423808073593	0.907423808073593	1
6423;	GO:2000035	regulation of stem cell division	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
6422; 6423;	GO:2000041	negative regulation of planar cell polarity pathway involved in axis elongation	2	2	100	0.000138679476933246	0.00416038430799737	0.129110593024852	0.133132297855916	0.109140748346464	0.128833234070985	0.0309726869659616
6424;	GO:2000051	negative regulation of non-canonical Wnt signaling pathway	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
6422;	GO:2000052	positive regulation of non-canonical Wnt signaling pathway	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
6422;	GO:2000054	negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
6422;	GO:2000080	negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
347;	GO:2000098	negative regulation of smooth muscle cell-matrix adhesion	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
2625;	GO:2000114	regulation of establishment of cell polarity	1	18	5.55555555555556	0.0882219949067566	0.127358067835318	1	1	0.907423808073593	0.907423808073593	0.948138747680206
6424;	GO:2000119	negative regulation of sodium-dependent phosphate transport	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
10457;	GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	1	30	3.33333333333333	0.139924021913819	0.174905027392274	1	1	0.907423808073593	0.907423808073593	1
7291;	GO:2000144	positive regulation of DNA-templated transcription, initiation	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
2192; 2625;	GO:2000146	negative regulation of cell motility	2	12	16.6666666666667	0.00203778608079697	0.0216852801389006	1	1	0.425897290886566	0.907423808073593	0.161439747818551
7291; 6363;	GO:2000147	positive regulation of cell motility	2	14	14.2857142857143	0.00267027330709002	0.0248879842214216	1	1	0.461957282126574	0.907423808073593	0.185282821835018
26471;	GO:2000194	regulation of female gonad development	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
6422;	GO:2000270	negative regulation of fibroblast apoptotic process	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
6422;	GO:2000271	positive regulation of fibroblast apoptotic process	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
7291;	GO:2000276	negative regulation of oxidative phosphorylation uncoupler activity	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
3776;	GO:2000279	negative regulation of DNA biosynthetic process	1	12	8.33333333333333	0.0612289019715984	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
2625;	GO:2000352	negative regulation of endothelial cell apoptotic process	1	30	3.33333333333333	0.139924021913819	0.174905027392274	1	1	0.907423808073593	0.907423808073593	1
57124;	GO:2000353	positive regulation of endothelial cell apoptotic process	1	17	5.88235294117647	0.083777116024585	0.123923006754394	1	1	0.907423808073593	0.907423808073593	0.92256585255994
347;	GO:2000405	negative regulation of T cell migration	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
2260;	GO:2000546	positive regulation of endothelial cell chemotaxis to fibroblast growth factor	1	4	25	0.0240038731582409	0.0671828519880796	1	1	0.857008849765549	0.907423808073593	0.500154142036207
6363;	GO:2000549	positive regulation of dendritic cell dendrite assembly	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
2625;	GO:2000553	positive regulation of T-helper 2 cell cytokine production	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
2625;	GO:2000607	negative regulation of cell proliferation involved in mesonephros development	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
2625;	GO:2000611	positive regulation of thyroid hormone generation	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
2625;	GO:2000617	positive regulation of histone H3-K9 acetylation	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
2192;	GO:2000647	negative regulation of stem cell proliferation	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
2625;	GO:2000664	positive regulation of interleukin-5 secretion	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
2625;	GO:2000667	positive regulation of interleukin-13 secretion	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
6363;	GO:2000669	negative regulation of dendritic cell apoptotic process	1	7	14.2857142857143	0.0381314611403215	0.0826325117262046	1	1	0.907423808073593	0.907423808073593	0.615171755644577
2625; 7291;	GO:2000679	positive regulation of transcription regulatory region DNA binding	2	16	12.5	0.00338318060702891	0.0297968200252088	1	1	0.49732754923325	0.907423808073593	0.221827482967824
2625;	GO:2000683	regulation of cellular response to X-ray	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
2625;	GO:2000703	negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
2625;	GO:2000734	negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
7291;	GO:2000773	negative regulation of cellular senescence	1	16	6.25	0.0793107862791833	0.120092042315483	1	1	0.907423808073593	0.907423808073593	0.894045587709397
7291;	GO:2000778	positive regulation of interleukin-6 secretion	1	24	4.16666666666667	0.114446477946567	0.152807536618504	1	1	0.907423808073593	0.907423808073593	1
7291;	GO:2000780	negative regulation of double-strand break repair	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
7291;	GO:2000793	cell proliferation involved in heart valve development	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
7291;	GO:2000802	positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
348;	GO:2000822	regulation of behavioral fear response	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
2260;	GO:2000830	positive regulation of parathyroid hormone secretion	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
3956;	GO:2001200	positive regulation of dendritic cell differentiation	1	6	16.6666666666667	0.0334449061858489	0.078119488901253	1	1	0.903012467017921	0.907423808073593	0.581573791399117
2335;	GO:2001202	negative regulation of transforming growth factor-beta secretion	1	2	50	0.014471553911037	0.0581497223322038	1	1	0.776647979875079	0.907423808073593	0.432905475460724
1281;	GO:2001223	negative regulation of neuron migration	1	11	9.09090909090909	0.0566537711269077	0.0996110261572004	1	1	0.907423808073593	0.907423808073593	0.741571187448853
56917;	GO:2001234	negative regulation of apoptotic signaling pathway	1	17	5.88235294117647	0.083777116024585	0.123923006754394	1	1	0.907423808073593	0.907423808073593	0.92256585255994
2260;	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	1	1	100	0.00967088926059922	0.0507325338260943	1	1	0.695125100453372	0.907423808073593	0.377686956987405
8406;	GO:2001241	positive regulation of extrinsic apoptotic signaling pathway in absence of ligand	1	12	8.33333333333333	0.0612289019715984	0.103667982174135	1	1	0.907423808073593	0.907423808073593	0.771773884951014
4318;	GO:2001243	negative regulation of intrinsic apoptotic signaling pathway	1	21	4.76190476190476	0.101428943859667	0.13950112622533	1	1	0.907423808073593	0.907423808073593	1
4318;	GO:2001258	negative regulation of cation channel activity	1	3	33.3333333333333	0.0192491787224047	0.0638195406695263	1	1	0.832592643219522	0.907423808073593	0.47511540019729
4318;	GO:2001268	negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	1	5	20	0.028735746167264	0.0725955692646671	1	1	0.879899043402449	0.907423808073593	0.540450034298067
